最新整形外科学大系　22　末梢神経障害、筋疾患、循環障害

出版社： 中山書店
著者：
発行日： 2007-12-10
分野： 臨床医学：外科  >  整形外科学
ISBN： 9784521723914
シリーズ： 最新整形外科学大系
電子書籍版： 2007-12-10 （第１版第１刷）
書籍・雑誌
≪全国送料無料でお届け≫
品切れ

33,000 円(税込)

電子書籍
章別単位で購入
ブラウザ、アプリ閲覧

33,000 円(税込)

購入する

目次

  • 最新整形外科学大系　22　末梢神経障害、筋疾患、循環障害

    ―目次―

    ［末梢神経疾患］
    １章　末梢神経の基礎
    ２章　末梢神経疾患の診察・診断
    ３章　末梢神経麻痺（絞扼性神経障害)
    ４章　胸郭出口症候群
    ５章　末梢神経疾患各論

    ［筋疾患］
    ６章　筋疾患の基礎
    ７章　筋疾患の診察・診断
    ８章　筋疾患各論

    ［循環障害］
    ９章　循環障害

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

1章 末梢神経の基礎

P.7 掲載の参考文献
1. 大野忠雄ほか. トートラ 人体の構造と機能. 第2版. 東京: 丸善; 2007. p.413-50.
 
2. 新見喜兵衛. 神経解剖学. 東京: 朝倉書店; 1976. p.16-24.
 
3. Smith BH, Kornblith PL. Axoplasmic transport in neurological surgery. Neurosurgery 1982; 10: 268-76.
PubMed
4. Droz B, et al. The smooth endoplasmic reticulum. Structure and role in the renewal of axonal membrane and synaptic vesicles by fast axonal transport. Brain Res 1975; 93: 1-13.
PubMed
5. 岩破康博. 末梢神経の解剖と生理. 平澤泰介監訳. 末梢神経の外科. 京都: 金芳堂; 1992. p.1-34.
 
6. Vale RD, et al. Identification of a novel force-generating protein, kinesin, involved in microtubule-based motility. Cell 1985; 42: 39-50.
PubMed
7. Paschal BM, Vallee RB. Retrograde transport by the microtubule-associated protein MAP IC. Nature 1987; 330: 181-3.
 
8. Lasek RJ, et al. Axonal-transport of the cytoplasmic matrix. J Cell Biol 1984; 99: s212-21.
 
9. Baas PW, Brown A. Slow axonal transport: The polymer transport model. Trends Cell Biol 1997; 7: 380-4.
PubMed
10. 田代朋子. 神経再生に伴う軸索内輸送変化と細胞骨格の変化. 志水義房ほか編. 神経の再生と機能再建. 新潟: 西村書店; 1997. p.199-215.
 
11. McMahon SB, et al. Immune and glial cell factors as pain mediators and modulators. Experimental Neurology 2005; 192: 444-62.
PubMed
12. Fambrough DM. Control of acetylcholine receptors in skeletal muscle. Physiol Rev 1979; 59: 165-226.
PubMed
13. Engle AG, Stonnington HH. Trophic function of the neuron. II. Denervation and regulation of muscle. Morphological effects of denervation of muscle. A quantitative ultrastructural study. Ann NY Acad Sci 1974; 228: 68-88.
 
14. 小原昭作. 末梢神経. 本郷利憲ほか編. 標準生理学. 東京: 医学書院; 1996.
 
P.14 掲載の参考文献
1. 大野忠雄ほか訳. トートラ 人体の構造と機能. 第2版. 東京: 丸善; 2007. p.451-70, 527-8.
 
2. 大西晃生ほか訳. 臨床神経学の基礎-メイヨー医科大学教材. 第3版. 東京: メディカル・サイエンス・インターナショナル; 1996. p.7-20.
 
3. Heanue TA, Pachnis V. Enteric nervous system development and Hirschsprung's disease: Advances in genetic and stem cell studies. Nat Rev Neurosci 2007; 8(6): 466-79.
PubMed
4. Sunderland S. The internal topography of the radial, median, and ulnar nerves. Brain 1945; 68: 243.
 
5. 伊藤鉄夫. 末梢神経の外科. 東京: 医学書院; 1981. p.88-144.
 
6. 和中明生. 神経系の発生. 遠山正彌編. 分子脳・神経機能解剖学. 京都: 金芳堂; 2004. p.603-24.
 
P.17 掲載の参考文献
1. Gold BG, et al. Regulation of axonal caliber, neurofilament content, and nuclear localization in mature sensory neurons by nerve growth factor. J Neurosci 1991; 11: 943-55.
PubMed
2. Rasmusson DD. Reorganization of raccoon somatosensory cortex following removal of the fifth digit. J Comp Neurol 1982; 205: 313-26.
PubMed
3. Waller A. Experiments on the section of the glossopharyngeal and hypoglossal nerves of the frog, and observations of the alterations produced thereby in the structure of their primitive fibers. Philos Trans R Soc Lond 1850; 140: 423-9.
 
4. Tomatsuri M, et al. Sprout formation at nodes of Ranvier of crush-injured peripheral nerves. Restor Neurol Neurosci 1993; 5: 275-82.
PubMed
5. 岩破康博. 末梢神経の解剖と生理. 平澤泰介監訳. 末梢神経の外科. 京都: 金芳堂; 1992. p.1-34.
 
6. Letournean PC. Neurite extension by peripheral and central nervous system in response to substratum bound fibronectin and laminin. Dev Biol 1983; 95: 212.
 
7. 岡島誠一郎ほか. 再生芽の形成と伸長. 志水義房ほか編. 神経の再生と機能再建. 基礎と臨床. 新潟: 西村書店; 1997. p.216-26.
 
8. Faissner A, Kruse J. J1/Tenascin is a repulsive substrate for central nervous system neurons. Neuron 1990; 5: 627-37.
PubMed
9. Dedkov EI, et al. Reparative myogenesis in long-term denervated skeletal muscles of adults rats results in a reduction of the satellite cell population. Anat Rec 2001; 263: 139-54.
 
10. Ashley S, et al. Atrophy, but not necrosis, in rabbit skeletal muscle denervated for periods up to one year. Am J Physiol Cell Physiol 2007; 292: C440-51.
PubMed
11. 埜中征哉. 臨床のための筋病理. 東京: 日本醫事新報社; 1993. p.29
 
12. Menderes A, et al. Effects of nerve growth factor on the neurotization of denervated muscle. Ann Plast Surg 2002; 48: 415-22.
PubMed
13. Iwata Y, et al. Fibroblast growth factor-2 enhances functional recovery of innervated muscle. Muscle Nerve 2006; 34: 623-30.
PubMed
14. Dellon AL, et al. The denervated Meissner corpuscle. A sequential histologic study following nerve devision in the Rhesus monkey. Plast Reconstr Surg 1975; 56: 182-93.
 
15. Dubovy P, Aldskogius H. Degeneration and regeneration of cutaneous sensory nerve formations. Microsc Res Tech 1996; 34(4): 362-75.
PubMed
P.20 掲載の参考文献
1. 大西晃生ほか訳. 臨床神経学の基礎-メイヨー医科大学教材. 第3版. 東京: メディカル・サイエンス・インターナショナル; 1996. p.305-16.
 
2. 幸原伸夫, 木村 淳. 神経伝導速度と筋電図を学ぶ人のために. 東京: 医学書院; 2005. p.54-7.
 
3. Sima AA. New insights into the metabolic and molecular basis for diabetic neuropathy. Cell Mol Life Sci 2003; 60: 2445-64.
PubMed
4. Tze WJ, et al. Effect of endocrine pancreas allotransplantation on diabetic nerve dysfunction. Metabolism 1985; 34: 721-31.
PubMed
5. Sima AA, et al. C-peptide prevents and improves chronic type 1 diabetic neuropathy in the BB/Wor-rat. Diabetologia 2001; 44: 889-97.
PubMed
6. Waller A. Experiments on the section of the glossopharyngeal and hypoglossal nerves of the frog, and observations of the alterations produced thereby in the structure of their primitive fibers. Philos Trans R Soc Lond 1850; 140: 423-9.
 
7. Vargas ME, Barres BA. Why is Wallerian degeneration in the CNS so slow? Annu Rev Neurosci 2007; 30: 153-79.
PubMed
8. 平澤泰介. 末梢神経損傷・障害の治療. 東京: 金原出版; 2000. p.30-1.
 

2章 末梢神経疾患の診察・診断

P.26 掲載の参考文献
1. The Italian General Practitioner Study Group.Chronic symmetric polyneuropathy in the elderly: A field screening investigation in two Italian regions. Neurology 1995; 45: 1832-6.
 
2. England D, Asbury AK. Peripheral Neuropathy. Lancet 2004; 363: 2151-61.
 
3. Schaumberg HH, et al. Disorders of Peripheral Nerves. 2nd ed. Philadelphia: FA Davis; 1992.
 
4. 馬場正之. 糖尿病に伴う神経障害: ポリニューロパチー. 日内会誌2004; 93: 1556-62.
 
5. 馬場正之. 薬剤性ニューロパチー. 小林祥泰, 水澤英洋編. 神経疾患最新の治療2006-2008. 東京: 南江堂; 2006. p.226-8.
 
6. Dyck PJ, et al. Intensive evaluation of referral unclassified neuropathies yields improved diagnosis. Ann Neurol 1981; 10: 222-6.
 
7. 日本神経学会用語委員会. 神経学用語集. 第2版. 東京: 文光堂; 1993. p.15-6.
 
8. Barohn R. Approach to peripheral neuropathy and neuronopathy. Semin Neurol 1998; 18: 7-18.
PubMed
9. Carleton S, Brown W. Changes in motor unit potentials in motor neuron diseases. J Neurol Neurosurg Psychiatry 1979; 42: 42-51.
 
10. Bourque P, Dyck PJ. Selective calf weakness suggests intraspinal pathology, not peripheral neuropathy. Arch Neurol 1990; 47:79-80.
 
11. 鈴木千恵子ほか. アキレス腱反射減弱を伴った30歳代の認知症例. 臨床脳波2007; 49: 65-8.
 
12. Baba M. Chronic inflammatory demyelinating polyneuropathy: Another hypertrophic neuropathy. Internal Med 1999; 38: 384-5.
 
13. Sabin T. Classification of peripheral neuropathy: The long and the short of it. Muscle Nerve 1986; 9: 711-9.
 
14. 馬場正之ほか. 多発性単神経炎型を呈した慢性炎症性脱髄性神経炎. 神経内科1985; 23: 575-80.
 
15. 馬場正之, 尾崎 勇. 慢性炎症性脱髄性ニューロパチーの診断と治療. 日本医事新報1997; 3843: 14-9.
 
16. Sumner CJ, et al. The spectrum of neuropathy in diabetes and impaired glucose tolerance. Neurology 2003; 60: 108-11.
PubMed
17. Said G. Indication and value of nerve biopsy. Muscle Nerve 1999; 22: 1617-9.
PubMed
P.32 掲載の参考文献
1. Brown WF, et al. Neuromuscular Function and Disease. Philadelphia: WB Saunders; 2002.
 
2. Kimura J. Electrodiagnosis in Diseases of Nerve and Muscle: Principles and Practice. New York: Oxford University Press; 2001.
 
3. 木村 淳, 幸原伸夫. 神経伝導検査と筋電図を学ぶ人のために. 東京: 医学書院; 2003.
 
4. 園生雅弘, 馬場正之. 神経筋電気診断の実際. 東京: 星和書店; 2004.
 
P.37 掲載の参考文献
1. Dyck PJ, Thomas PK. Peripheral Neuropathy. 4th ed. Philadelphia: WB Saunders; 2005.
 
2. Ouvier RA, et al. Peripheral Neuropathy in Childhood. 2nd ed. London: Mac Keith Press; 1999.
 
3. Bromberg MB, Smith AC. Handbook of peripheral neuropathy. Boca Raton, FL: CRC Press; 2005.
 
P.42 掲載の参考文献
1. Asbury AK, Gilliatt RW. The clinical approach to neuropathy. In: Asbury AK, Gilliatt RW, editors. Peripheral Nerve Disorders. London: Butterworths; 1984. p.1-20.
 
2. Thomas PK. Biopsy of peripheral nerve tissue. In: Asbury AK, Thomas PK, editors. Peripheral Nerve Disorders 2. Oxford: Butterworth-Heinemann; 1995. p.281-300.
 
3. 馬場正之. ニューロパチーの診断に神経バイオプシーは必要か. 臨床検査1996; 40: 824-5.
 
4. Said G. Indications and value of nerve biopsy. Muscle Nerve 1999; 22: 1617-9.
PubMed
5. Asbury AK, Johnson PC. Pathology of Peripheral Nerve. Philadelphia: WB Saunders; 1977.
 
6. Dyck PJ, et al. Pathologic alterations of nerves. In: Dyck PJ, Thomas PK, editors. Peripheral Neuropathy. Philadelphia: WB Saunders; 1993. p.514-95.
 
7. King RHM. Atlas of Peripheral Nerve Pathology. London: Arnold; 1999.
 
8. 神田 隆. 末梢性ニューロパチーの病理形態学. 神経研究の進歩2003; 47: 481-91.
 
9. 額田 均. 末梢神経の病理: 神経生検から糖尿病・虚血の病理まで. 末梢神経2004; 15: 53-61.
 
10. Dyck PJ, et al. Nonsystemic vasculitic neuropathy. Brain 1987; 110: 843-53.
PubMed
11. Gabriel CM, et al. Prospective study of the usefulness of sural nerve biopsy. J Neurol Neurosurg Psychiatry 2000; 69: 442-6.
PubMed
12. Said G, et al. Nerve granulomas and vasculitis in sarcoid peripheral neuropathy: A clinicopathological study of 11 patients. Brain 2002; 125: 264-75.
PubMed
13. Corbo M, et al. Motor nerve biopsy studies in motor neuropathy and motor neuron disease. Muscle Nerve 1997; 20: 15-21.
PubMed
14. Moore FG, et al. The role of MRI and nerve root biopsy in the diagnosis of neurosarcoidosis. Can J Neurol Sci 2001; 28: 349-53.
PubMed
15. Griffin JW, et al. Assessment of cutaneous innervation by skin biopsies. Curr Opin Neurol 2001; 14: 655-9.
PubMed
16. Nukada H, et al. The clinical spectrum and morphology of type II hereditary sensory neuropathy. Brain 1982; 105: 647-65.
PubMed
17. Pollock M, et al. Comparison between fascicular and whole sural nerve biopsy. Ann Neurol 1983; 13: 65-8.
PubMed
18. 木村 淳, 幸原伸夫. 神経伝導検査と筋電図を学ぶ人のために. 東京: 医学書院; 2003.
 
19. 園生雅弘, 馬場正之. 神経筋電気診断の実際. 東京: 星和書店; 2004.
 

3章 末梢神経麻痺 (絞扼性神経障害)

P.47 掲載の参考文献
1. 安藤昌代ほか. 副神経の僧帽筋支配についての解剖学的研究. 日手会誌1992; 9: 288-91.
 
2. 冲永修二ほか. 医原性副神経麻痺の治療. 日手会誌1992; 8: 977-80.
 
3. Chan PK, Hems TE. Clinical signs of accessory nerve palsy. J Trauma 2006; 60: 1142-4.
PubMed
4. Okajima S, et al. Surgical treatment for spinal accessory nerve injury. Microsurgery 2006; 26: 273-7.
PubMed
P.52 掲載の参考文献
1. Mikami Y, et al. Results of nerve grafting for injuries of the axillary and suprascapular nerves. J Bone Joint Surg Br 1997; 79: 527-31.
PubMed
2. Cummins CA, et al. Anatomy and histological characteristics of the spinoglenoid ligament. J Bone Joint Surg Am 1998; 80: 1622-5.
PubMed
3. Ferretti A, et al. Suprascapular neuropathy in volleyball players. J Bone Joint Surg Am 1987; 69: 260-3.
PubMed
4. Ollat D, et al. Ganglion cyst of the shoulder: Six cases and review of the literature. Rev Chir Orthop Reparatrice Appar Mot 2006; 92: 214-22.
PubMed
5. Terzis JK, et al. Restoration of shoulder function with nerve transfers in traumatic brachial plexus palsy patients. Microsurgery 2006; 26: 316-24.
PubMed
P.55 掲載の参考文献
1. Wiater JM, Flatow EL. Long thoracic nerve injury. Clin Orthop Relat Res 1999; 368: 17-27.
PubMed
P.59 掲載の参考文献
1. Coene LNJEM, et al. Surgical management of axillary nerve lesions, isolated or combined with other infraclavicular nerve lesions. Peripheral Nerve Repair and Re-generation 1986; 3: 47-65.
 
2. 辻野昭人ほか. 投球肩における腋窩神経障害. 肩関節2004; 29: 60.
 
3. 落合直之ほか. 腕神経叢損傷-腋窩, 肩甲上神経損傷例の治療と予後. 日手会誌1988; 5: 151-5.
 
P.67 掲載の参考文献
1. Werner CO. Radial nerve paralysis and tumor. Clin Orthop Relat Res 1991; 268: 223-5.
PubMed
2. Ogino T, et al. Diagnosis of radial nerve palsy caused by ganglion with use of different imaging techniques. J Hand Surg[Am]1991; 16: 230-5.
PubMed
3. 松峯昭彦ほか. 橈骨神経内転移を来たした滑膜肉腫の1例. 中部整災誌2005; 48: 621-2.
 
4. Samardzic M, et al. Radial nerve lesions associated with fractures of the humeral shaft. Injury 1990; 21: 220-2.
PubMed
5. Shah JJ, et al. Radial nerve paralysis associated with fractures of the humerus. A review of 62 cases. Clin Orthop Ralat Res 1983; 172: 171-6.
 
6. Seddon H. Surgical Disorders of the Peripheral Nerves. 2nd ed. Edinburgh: Churchill Livingstone; 1975.
 
7. Tsuge K. Tendon transfers for radial nerve palsy. Aust N Z J Surg 1980; 50: 267-72.
PubMed
8. Riordan DC. Radial nerve paralysis. Orthop Clin North Am 1974; 5: 283-7.
PubMed
9. Boyes JH. Tendon transfers for radial nerve palsy. Bull Hosp Joint Dis 1960; 21: 97-105.
 
P.75 掲載の参考文献
1. Ramachandran M, et al. Clinical outcome of nerve injuries associated with supracondylar fractures of the humerus in children: The experience of a specialist referral centre. J Bone Joint Surg Br 2006; 88: 90-4.
PubMed
2. Limb D, et al. Median nerve palsy after posterolateral elbow dislocation. J Bone Joint Surg Br 1994; 76: 987-8.
PubMed
3. Lee KS, et al. An anatomic study of the Martin-Gruber anastomosis: Electrodiagnostic implications. Muscle Nerve 2005; 31: 95-7.
 
4. Riordan DC. Tendon transfers for median and ulnar palsies. Hand 1969; 1: 42-6.
 
5. Camitz H. Uber die Behandlung der Oppositionslahmung. Acta Chir Scand 1929; 65: 77-81.
 
6. Foucher G, et al. Primary palmaris longus transfer as an opponens plasty in carpal tunnel release; A series of 73 cases. J Hand Surg[Br]1991; 16: 56-60.
 
7. 津下健哉. 私の手の外科-手術アトラス. 改訂第3版. 東京: 南江堂; 1995.
 
8. Okutsu I, et al. Endoscopic management of carpal tunnel syndrome. Arthroscopy 1989; 5: 11-8.
PubMed
9. Chow JC. Endoscopic release of the carpal ligament; A new technique for carpal tunnel syndrome. Arthroscopy 1989; 5: 19-24.
 
P.84 掲載の参考文献
1. Moore KL. The upper limb. In: Moor KL, editor. Clinically Oriented Anatomy. 2nd ed. Baltimore: Williams & Wilkins; 1985. p.626-793.
 
2. 津下健哉. 尺骨神経管症候群. 津下健哉編. 手の外科の実際. 第5版. 東京: 南江堂; 1974. p.553-5.
 
3. Zancolli EA. Claw-hand caused by paralysis of the intrinsic muscles. A simple surgical procedure for its correction. J Bone Joint Surg Am 1957; 39: 1076-80.
PubMed
4. Parkes A. Paralytic claw fingers-A graft tenodesis operation. Hand 1973; 5: 192-9.
PubMed
5. Fowler SB. Extensor apparatus of the digits. J Bone Joint Surg Br 1949; 31: 477.
 
6. Tsuge K. Tendon transfers in median and ulnar paralysis. Hiroshima Med J Sci 1967; 16: 29-48.
 
7. Riordan DC. Tendon transfers for nerve paralysis of the hand and wrist. Curr Pract Orthop Surg 1964; 2: 17-40.
 
8. Zancolli EA. Correction of simple clawhand with available muscular Motors. The“Lasso"surgical technique. In: Structural and Dynamic Basis of Hand Surgery. 2nd ed. Philadelphia: Lippincott; 1979. p.174-80.
 
9. Brand PW. Tendon grafting. Illustrated by a new operation for intrinsic paralysis of the fingers. J Bone Joint Surg Br 1961; 43: 444-53.
 
10. Riordan DC. Tendon transplantations in median-nerve and ulnar-nerve paralysis. J Bone Joint Surg Am 1953; 35: 312-20.
PubMed
11. Enna CD, Riordan DC. The Fowler procedure for correction of the paralytic claw hand. Plast Reconstr Surg 1973; 52: 352-60.
PubMed
12. Boyes JH, editor. Bunnell's Surgery of the Hand. 4th ed. Philadelphia: JB Lippincott; 1964. p.514.
 
13. Smith RJ. Extensor carpi radialis brevis tendon transfer for thumb adduction-A study of power pinch. J Hand Surg 1983; 8: 4-15.
PubMed
14. Omer GE Jr. Reconstruction of a balanced thumb through tendon transfers. Clin Orthop Relat Res 1985; 195: 104-16.
PubMed
15. Osborne G. The surgical treatment of tardy ulnar neuritis: Proceedings and reports of councils and associations. J Bone Joint Surg Br 1957; 39: 782.
 
16. Learmonth JR. Technique for transplanting the ulnar nerve. Surg Gynecol Obstet 1942; 75: 792-3.
 
17. King T, Morgan Fp.Late results of removing the medial humeral epicondyle for traumatic ulnar neuritis. J Bone Joint Surg Br 1959; 41: 51-5.
PubMed
P.88 掲載の参考文献
1. 加藤博之ほか. 前骨間神経麻痺と後骨間神経麻痺-臨床像と治療成績. 整・災外1997; 40: 587-97.
 
2. Kiloh LG, et al. Isolated neuritis of the anterior interosseous nerve. Br Med J 1952; 1: 850-1.
PubMed
3. Nagano A, et al. Spontaneous anterior interosseous nerve palsy with hourglass-like fascicular constriction within the main trunk of the median nerve. J Hand Surg 1996; 21: 266-70.
PubMed
4. 田尻康人. 特発性前骨間神経麻痺に対する神経線維束間剥離術の手術時期の検討. 長野昭編. 別冊整形外科 No 49 末梢神経障害の基礎と治療戦略. 東京: 南江堂; 2006. p.182-5.
 
5. 柴田圭一ほか. 特発性前骨間神経麻痺における神経線維束間剥離術の必要性. 日手会誌1994; 10: 985-9.
 
P.93 掲載の参考文献
1. 仲尾保志ほか. 肘周辺の神経障害 回復度からみた手術適応のタイミング. 越智隆弘, 菊地臣一編. NEW MOOK 整形外科11. 肘の外科. 東京: 金原出版; 2002. p.191-7.
 
2. Werner CO. Paralysis of the posterior interosseous nerve caused by tumour: Brief report. J Bone Joint Surg Br 1987; 69: 670-1.
PubMed
3. Millender LH, et al. Posterior interosseous-nerve syndrome secondary to rheumatoid synovitis. J Bone Joint Surg Am 1973; 55: 753-7.
PubMed
4. Spinner M, et al. Posterior interosseous nerve palsy as a complication of Monteggia fractures in children. Clin Orthop Relat Res 1968; 58: 141-5.
PubMed
5. Hirachi K, et al. Clinical features and management of traumatic posterior interosseous nerve palsy. J Hand Surg[Br]1998; 23: 413-7.
PubMed
6. Kotani H, et al. Posterior interosseous nerve paralysis with multiple constrictions. J Hand Surg[Am]1995; 20: 15-7.
PubMed
P.97 掲載の参考文献
1. Ehrlich W, et al. Classical article: Cheiralgia paresthetica(entrapment of the radial nerve). A translation in condensed form of Robert Wartenberg's original article published in 1932. J Hand Surg[Am]1986; 11: 196-9.
 
2. Turkof E, et al. The radial sensory nerve entrapped between the two slips of a split brachioradialis tendon: A rare aspect of Wartenberg's syndrome. J Hand Surg[Am]1995; 20: 676-8.
PubMed
3. Tosun N, et al. Entrapment of the sensory branch of the radial nerve(Wartenberg's syndrome): An unusual cause. Tohoku J Exp Med 2001; 193: 251-4.
PubMed
4. Lanzetta M, Foucher G. Entrapment of the superficial branch of the radial nerve(Wartenberg's syndrome). A report of 52 cases. Int Orthop 1993; 17: 342-5.
PubMed
5. Plate AM, Green SM. Compressive radial neuropathies. Instr Course Lect 2004; 49: 295-304.
 
6. Spindler HA, Dellon AL. Nerve conduction studies in the superficial radial nerve entrapment syndrome. Muscle Nerve 1990; 13: 1-5.
PubMed
7. Trifonidis M, et al. Superficial branch of the radial nerve piercing the brachioradialis tendon to become subcutaneous: An anatomical variation with clinical relevance. Hand Surg 2004; 9: 191-5.
 
8. Dellon AL, Mackinnon SE. Treatment of the painful neuroma by neuroma resection and muscle implantation. Plast Reconstr Surg 1966; 77: 427-38.
 
P.101 掲載の参考文献
1. Dobyns JH, et al. Bowler's thumb: Diagnosis and treatment. A review of seventeen cases. J Bone Joint Surg Am 1972; 54: 751-5.
 
2. Howell AE, Leach RE. Bowler's thumb. Perineural fibrosis of the digital nerve. J Bone Joint Surg Am 1970; 52: 379-81.
 
3. Rayan GM, O'Donoghue DH. Ulnar digital compression neuropathy of the thumb caused by splinting. Clin Orthop Relat Res 1983; 175: 170-2.
PubMed
4. De Smet L, et al. Bowler's thumb treated by translocation of the digital nerve. Acta Orthop Belg 1999; 65: 367-8.
 
P.105 掲載の参考文献
1. Wilson SAK. Neurology. 2nd ed. Baltimore: Williams Wilkins; 1955.
 
2. Bernhardt M. Uber isoliert im Gebiete des N. cutaneous femoris externus vorkommende Paresthesien. Neurol Centralbl 1895; 14: 242-4.
 
3. Roth VK. Meralgia Paresthetica. Med Obozr 1895; 43: 678.
 
4. de Ridder VA, et al. Anatomical variations of the lateral femoral cutaneous nerve and the consequences for surgery. J Orthop Trauma 1999; 13: 207-11.
PubMed
5. Kho KH, et al. Meralgia paresthetica after strenuous exercise. Muscle Nerve 2005; 31: 761-3.
PubMed
6. Korkmaz N, Ozcakar L. Meralgia paresthetica in a policeman: The belt or the gun. Plast Reconstr Surg 2004; 114: 1012-3.
PubMed
7. Trummer M, et al. Lumbar disc herniation mimicking meralgia paresthetica: Case report. Surg Neurol 2000; 54: 80-1.
PubMed
8. Weikel AM, Habal MB. Meralgia paresthetica: A complication of iliac bone procurement. Plast Reconstr Surg 1977; 60: 572-4.
PubMed
9. Polidori L, et al. Meralgia paresthetica as a complication of laparoscopic appendectomy. Surg Endosc 2003; 17: 832.
PubMed
10. Yang SH, et al. Postoperative meralgia paresthetica after posterior spine surgery: Incidence, risk factors, and clinical outcomes. Spine 2005; 30: E547-50.
PubMed
11. Russo MJ, et al. Nerve conduction studies of the lateral femoral cutaneous nerve. Implications in the diagnosis of meralgia paresthetica. Am J Electroneurodiagnostic Technol 2005; 45: 180-5.
PubMed
12. Seror P, Seror R. Meralgia paresthetica: Clinical and electrophysiological diagnosis in 120 cases. Muscle Nerve 2006; 33: 650-4.
PubMed
13. Heim A, et al. Meralgia paresthetica: A retrospective analysis of 79 patients evaluated and treated according to a standard algorithm. Acta Orthop 2006; 77: 482-6.
 
14. Nahabedian MY, Dellon AL. Meralgia paresthetica: Etiology, diagnosis, and outcome of surgical decompression. Ann Plast Surg 1995; 35: 590-4.
PubMed
15. Siu TL, Chandran KN. Neurolysis for meralgia paresthetica: An operative series of 45 cases. Surg Neurol 2005; 63: 19-23.
 
16. Williams PH, Trzil Kp.Management of meralgia paresthetica. J Neurosurg 1991; 74: 76-80.
PubMed
17. van Eerten PV, et al. Operative treatment of meralgia paresthetica: Transection versus neurolysis. Neurosurgery 1995; 37: 63-5.
PubMed
18. Ducic I, et al. Decompression of the lateral femoral cutaneous nerve in the treatment of meralgia paresthetica. J Reconstr Microsurg 2006; 22: 113-8.
PubMed
P.109 掲載の参考文献
1. Yeoman W. The relation of arthritis of the sacroiliac joint to sciatica. Lancet 1928; 2: 1119-22.
 
2. Freiberg AH. Sciatic pain and its relief by operations on muscle and fascia. Arch Surg 1937; 34: 337-49.
 
3. Robinson D. Piriformis syndrome in relation to sciatic pain. Am J Surg 1947; 73: 355-8.
 
4. Parziale JR, et al. The piriformis syndrome. Am J Orthop 1996; 25: 819-23.
PubMed
5. Beaton LE, et al. The sciatic nerve and the piriformis muscle: Their interrelation a possible cause of coccygodynia. J Bone Joint Surg Br 1938; 3: 686-8.
 
6. Pecina M. Contribution to the etiological explanation of the piriformis syndrome. Acta Anat(Basel)1979; 105: 181-7.
 
7. 村上正純. 梨状筋症候群. ペインクリニック1999; 29: 112-4.
 
8. Pace JB, et al. Piriform syndrome. West J Med 1976; 124: 435-9.
 
9. Fishman LM, et al. Electrophysiologic evidence of piriformis syndrome. Arch Phys Med Rehabil 1992; 73: 359-64.
PubMed
10. Jankiewicz JJ, et al. The appearance of the piriformis muscle syndrome in computed tomography and magnetic resonance imaging. A case report and review of the literature. Clin Orthop Relat Res 1991; 262: 205-9.
PubMed
11. 荻元晋作ほか. 梨状筋症候群の1例. 整形外科2006; 57: 162-4
 
12. Papadopourous SM, et al. Pseudoaneurysm of the inferior gluteal artery presenting as sciatic nerve compression. Neurosurgery 1989; 24: 926-8.
 
13. Swezey R. Obturator internus bursitis: A common factor in low back pain. Orthopaedics 1993; 16: 783-5.
PubMed
14. Barton PM. Piriformis syndrome: A rational approach to management. Pain 1991; 47: 345-52.
PubMed
15. Hallin Rp.Sciatic pain of the piriformis muscle. Postgrad Med 1983; 74: 69-72.
PubMed
16. Durrani Z. Piriformis muscle syndrome: An undiagnosed cause of sciatica. J Pain Symptom Manage 1991; 6: 374-9.
 
17. Benzon HT, et al. Piriformis syndrome: Anatomic considerations, a new injection technique, and a review of the literature. Anesthesiology 2003; 98: 1442-8.
 
18. Porta M. A comparative trial of botulinum toxin type A and methylprednisolone for the treatment of myofascial pain syndrome and pain from chronic muscle spasm. Pain 2000; 85: 101-5.
 
19. Hughes SS, et al. Extrapelvic compression of the sciatic nerve. J Bone Joint Surg Am 1992; 74: 1553-9.
PubMed
P.114 掲載の参考文献
1. Bradshaw C, et al. Obturator nerve entrapment. A cause of groin pain in athletes. Am J Sports Med 1997; 25: 402-8.
PubMed
2. Warwick R, Williams RL, editors. Gray's Anatomy. 35th ed. Edinburgh: Longman Group Publishers; 1973. p.1052-3.
 
3. Harvey G, et al. Obturator neuropathy. An anatomic perspective. Clin Orthop Relat Res 1999; 363: 203-11.
PubMed
4. Barrick EF. Entrapment of the obturator nerve in association with a fracture of the pelvic ring. A case report. J Bone Joint Surg Am 1998; 80: 258-61.
 
5. Leno C, et al. Bilateral obturator neuralgia secondary to osteitis of the pubis. Arch Neurobiol 1984; 47: 347-52.
PubMed
6. Rogers LR, et al. Obturator mononeuropathy caused by pelvic cancer: Six cases. Neurology 1993; 43: 1489-92.
PubMed
7. Mondelli M, et al. Obturator neuropathy due to obturator hernia. Muscle Nerve 2002; 26: 291-2.
PubMed
8. Nogajski JH. Postpartum obturator neuropathy. Neurology 2004; 63: 2450-1.
PubMed
9. Siliski JM, et al. Obturator-nerve palsy resulting from intrapelvic extrusion of cement during total hip replacement. Report of four cases. J Bone Joint Surg Am 1985; 67: 1225-8.
 
10. Sunderland S. Nerves and Nerve Injuries. 2nd ed. Edinburgh: Churchill Livingstone; 1978.
 
11. Stewart JD. Focal Peripheral Neuropathies. 2nd ed. New York: Raven Press; 1993.
 
12. Sorenson EJ, et al. Obturator neuropathy: Causes and outcome. Muscle Nerve 2002; 25: 605-7.
PubMed
P.118 掲載の参考文献
1. 松崎昭夫. 伏在神経の絞扼性障害. 骨・関節・靱帯1994; 7: 899-905.
 
2. Kopell HP, Thompson WAL. Knee pain due to saphenous nerve entrapment. N Engl J Med 1960; 263: 351-3.
 
3. Mozes M, et al. Saphenous nerve entrapment simulating vascular disorder. Surgery 1975; 77: 299-303.
PubMed
4. Worth RM, et al. Saphenous nerve entrapment. A cause of medial knee pain. Am J Sports Med 1984; 12: 80-1.
PubMed
5. Romanoff ME, et al. Saphenous nerve entrapment at the adductor canal. Am J Sports Med 1989; 17: 478-81.
 
6. Wartenberg R. Digitalgia paresthetica and gonyalgia paresthetica. Neurology 1954; 4: 106-15.
PubMed
7. Dumitru D, editor. Electrodiagnostic Medicine. Philadelphia: Hanley and Belfus; 1995.
 
8. Murayama K, et al. Entrapment of the saphenous nerve by branches of the femoral vessels. A report of two cases. J Bone Joint Surg Am 1991; 73: 770-2.
 
9. Fabian RH, et al. Letter: Surfer's neuropathy. N Engl J Med 1987; 316: 555.
PubMed
10. 宮坂敏幸ほか. 伏在神経絞扼性神経障害21例の検討. 整形外科1994; 45: 443-7.
 
11. 斉藤明義ほか. 膝周辺のスポーツ障害. ペインクリニック1991; 12: 477-84.
 
12. Helmer DE, et al. Saphenous nerve entrapment caused by pes anserine bursitis mimicking stress fracture of the tibia. Arch Phys Med Rehabil 1991; 72: 336-7.
 
13. Dumitru D, Windsor RE. Subsartorial entrapment of the saphenous nerve of a competitive. Physician Sportsmed 1989; 17: 116-25.
 
14. Tranier S, et al. Value of somatosensory evoked potentials in saphenous entrapment neuropathy. J Neurol Neurosurg Psychiatry 1992; 55: 461-5.
PubMed
15. Lumsden DB, Kalenak A. The saphenous nerve: An external method for identifying its exit from the adductor canal. Orthop Rev 1993; 22: 451-5.
PubMed
16. House JH, Ahmed K. Entrapment neuropathy of the infrapatellar branch of the saphenous nerve. Am J Sports Med 1977; 5: 217-24.
PubMed
17. Lippitt AB. Neuropathy of the saphenous nerve as a cause of knee pain. Bull Hosp Jt Dis 1993; 52: 31-3.
PubMed
18. Luerssen TG, et al. Spontaneous saphenous neuralgia. Neurosurgery 1996; 329: 216-22.
 
P.121 掲載の参考文献
1. Kopell HP, Thompson WA. Peripheral entrapment neuropathies of the lower extremity. N Engl J Med 1960; 262: 56-60.
PubMed
2. Dellon AL, et al. Tibial nerve branching in the tarsal tunnel. Arch Neurol 1984; 41: 645-6.
PubMed
3. Mann RA. Tarsal tunnel syndrome. Orthop Clin North Am 1974; 5: 109-15.
PubMed
4. Mann RA. Disease of the nerves. Tarsal tunnel syndrome. In: Coughlin MJ, Mann RA, editors. Surgery of the Foot and Ankle. 7th ed. St Louis: Mosby; 1999. p.512-6.
 
5. 佐藤勤也ほか. 足根管症候群の電気生理学的診断法. 臨床脳波1988; 30: 150-3.
 
P.123 掲載の参考文献
1. Morton TG. A peculiar and painful affection of the fourth phalangeal articulation. Am J Med Sci 1876; 71: 37-45.
 
2. 中村俊康. Morton病. MB Orthop 1999; 12: 37-40.
 

4章 胸郭出口症候群

P.135 掲載の参考文献
1. Abe M, et al. Diagnosis, treatment and complications of thoracic outlet syndromes. J Orthop Sci 1999; 4: 66-9.
PubMed
2. Nishida J, et al. Double crush syndrome related to the thoracic outlet syndrome. Hand Surg 1997; 2: 131-3.
 
3. 西田 淳ほか. 胸郭出口症候群の治療成績. 日手会誌1999; 14: 462-6.
 
4. Clein LJ. The droopy shoulder syndrome. Can Med Assoc J 1976; 114: 343-4.
PubMed
5. 西田 淳ほか. 胸郭出口症候群と脊椎脊髄疾患. 脊椎脊髄2003; 16: 1093-7.
 
6. 西田 淳ほか. 職業関連の胸郭出口症候群. 日災医誌1999; 47: 296-301.
 
7. 西田 淳ほか. 肩凝りと胸郭出口症候群; 特に症状誘発試験に関して. Pharma Medica 1994; 12: 23-7.
Medical*Online
8. Abe M, et al. Diagnosis and treatment of thoracic outlet syndrome. J Orthop Sci 1997; 2: 119-27.
 
9. 阿部正隆ほか. 胸郭出口症候群の診断と保存療法. 末梢神経1998; 5: 77-83.
 
10. Morley J. Brachial pressure neuritis due to a normal thoracic first rib; Its diagnosis and treatment by excision of rib. Clin J 1913; 22: 461.
 
11. Wright CIS. The neurovascular syndrome produced by hypaerabduction of the arms. Am Heart J 1945; 29: 1-19.
 
12. Eden KC. The vascular complication of cervical ribs and first thoracic rib abnormalities. Br J Surg 1939; 27: 111-39.
 
13. Roos DB. New concepts of thoracic outlet syndrome that explain etiology, symptoms, diagnosis, and treatment. Vascular Surg 1979; 13: 313-21.
 
14. 嶋村 正ほか. 有痛性疾患. いわゆる頚腕痛. 室田景久, 矢部 裕編. 整形外科非観血的治療法のコツ. 東京: 全日本病院出版会; 1996. p.10-3.
 
15. 嶋村 正ほか. 胸郭出口症候群と頚椎頚髄疾患. 脊椎脊髄1996; 9: 517-22.
 
16. 嶋村 正ほか. 胸郭出口症候群と頚椎疾患. 東日本臨整会誌1994; 6: 431-4.
 
17. 西田 淳, 嶋村 正. 胸郭出口への経腋窩アプローチ. 岩本幸英編. 新OS NOW No. 28 Usefull Surgical Approach-定型からオリジナルまで. 東京: メジカルビュー社; 2005. p.43-5.
 
18. 川上 登. 有痛性痙縮を分析する. 心身医学的側面から. Medical Digest 1977; 26: 16-21.
 

5章 末梢神経疾患各論

P.151 掲載の参考文献
1. Charcot JM, Marie p.Sur une forme particulaire d'atrophie musculaire progressive souvent familial debutant par les pieds et les jambes et atteignant plus tard les mains. Rev Med 1886; 6: 97-138.
 
2. Saifi GM, et al. Molecular mechanisms, diagnosis, and rational approaches to management of and therapy for Charcot-Marie-Tooth disease and related peripheral neuropathies. J Investig Med 2003; 51: 261-83.
PubMed
3. 中川正法, 高嶋 博. 遺伝性ニューロパチーupdate. 臨床神経2004; 44: 991-4.
 
4. 高嶋 博. 遺伝性ニューロパチーの分子遺伝学. 臨床神経2006; 46: 1-18.
 
5. Suter U, Scherer SS. Disease mechanisms in inherited neuropathies. Nat Rev Neurosci 2003; 4: 714-26.
PubMed
6. Lupski JR, et al. DNA duplication associated with Charcot-Marie-Tooth disease type 1A. Cell 1991; 66: 219-32.
PubMed
7. Patel PI, et al. The gene for the peripheral myelin protein PMP-22 is a candidate for Charcot-Marie-Tooth disease type 1A. Nat Genet 1992; 1: 159-65.
PubMed
8. 早坂 清. 遺伝性ニューロパチーの分子生物学. 神経内科2004; 61: 532-8.
 
9. Hayasaka K, et al. Charcot-Marie-Tooth neuropathy type 1B is associated with mutations of the myelin P0 gene. Nat Genet 1993; 5: 31-4.
PubMed
10. Bergoffen J, et al. Connexin mutations in X-linked Charcot-Marie-Tooth disease. Science 1993; 262: 2039-42.
 
11. Hattori N, et al. Demyelinating and axonal features of Charcot-Marie-Tooth disease with mutations of myelin-related proteins(PMP22, MPZ and Cx32): A clinicopathological study of 205 Japanese patients. Brain 2003; 126(Pt 1): 134-51.
 
12. Ginsberg L, et al. Coexistent hereditary and inflammatory neuropathy. Brain 2004; 127: 193-202.
PubMed
13. Roper BA, Tibrewal SB. Soft tissue surgery in Charcot-Marie-Tooth disease. J Bone Joint Surg Br 1989; 71: 17-20.
PubMed
14. Dejerine J, Sottas J. Sur la nevrite interstitielle, hypertrophique et progressive de l'enfance. C R Soc Biol 1983; 45: 63-96.
 
15. Plante-Bordeneuve V, Said G. Dejerine-Sottas disease and hereditary demyelinating polyneuropathy of infancy. Muscle Nerve 2002; 26: 608-21.
PubMed
16. Kennedy WR, et al. A case of congenital hypomyelination neuropathy. Clinical, morphological, and chemical studies. Arch Neurol 1977; 34: 337-45.
PubMed
17. Roa BB, et al. Dejerine-Sottas syndrome associated with point mutation in the peripheral myelin protein 22(PMP22)gene. Nat Genet 1993; 5: 269-73.
PubMed
18. Hayasaka K, et al. De novo mutation of the myelin P0 gene in Dejerine-Sottas disease(hereditary motor and sensory neuropathy type III). Nat Genet 1993; 5: 266-8.
PubMed
19. Schady W, Lascelles RG. Dejerine-Sottas neuropathy(HMSN III)and Roussy-Levy syndrome. In: Vinken PJ, et al, editors. Handbook of Clinical Neurology, vol 60: Hereditary Neuropathies and Spinocerebellar Atrophy. Amsterdam: Elsevier; 1991. p.213-24.
 
20. Pareyson D. Differential diagnosis of Charcot-Marie-Tooth disease and related neuropathies. Neurol Sci 2004; 25: 72-82.
PubMed
21. Behse F, et al. Hereditary neuropathy with liability to pressure palsies. Electrophysiological and histopathological aspects. Brain 1972; 95: 777-94.
PubMed
22. Chance PF, et al. DNA deletion associated with hereditary neuropathy with liability to pressure palsies. Cell 1993; 72: 143-51.
PubMed
23. Keller MP, Chance PF. Inherited neuropathies: From gene to disease. Brain Pathol 1999; 9: 327-41.
PubMed
24. Chance PF. Hereditary neuropathy with liability to pressure palsies. In: Noseworthy JH, editor. Neurological Therapeutics: Principles and Practice. 2nd ed. Abingdon: Informa Healthcare; 2006. p.2488-95.
 
25. Dubourg O, et al. Guidelines for diagnosis of hereditary neuropathy with liability to pressure palsies. Neuromuscul Disord 2000; 10: 206-8.
PubMed
26. Ohkoshi N, et al. Acute vocal cord paralysis in hereditary neuropathy with liability to pressure palsies. Neurology 2001; 56: 1415.
PubMed
27. Dyck PJ. Neuronal atrophy and degeneration predominantly affecting peripheral sensory and autonomic neurons. In: Dyck PJ, et al, editors. Peripheral Neuropathy. Philadelphia: WB Saunders; 1993. p.1065-93.
 
28. Bejaoui K, et al. SPTLC1 is mutated in hereditary sensory neuropathy, type 1. Nat Genet 2001; 27: 261-2.
PubMed
29. Lafreniere RG, et al. Identification of a novel gene(HSN2)causing hereditary sensory and autonomic neuropathy type II through the Study of Canadian Genetic Isolates. Am J Hum Genet 2004; 74: 1064-73.
 
30. Slaugenhaupt SA, et al. Tissue-specific expression of a splicing mutation in the IKBKAP gene causes familial dysautonomia. Am J Hum Genet 2001; 68: 598-605.
PubMed
31. Indo Y, et al. Mutations in the TRKA/NGF receptor gene in patients with congenital insensitivity to pain with anhidrosis. Nat Genet 1996; 13: 485-8.
PubMed
32. Houlden H, et al. A novel TRK A(NTRK1)mutation associated with hereditary sensory and autonomic neuropathy type V. Ann Neurol 2001; 49: 521-5.
PubMed
33. Einarsdottir E, et al. A mutation in the nerve growth factor beta gene(NGFB)causes loss of pain perception. Hum Mol Genet 2004; 13: 799-805.
PubMed
34. Irobi J, et al. Molecular genetics of distal hereditary motor neuropathies. Hum Mol Genet 2004; 13(Spec No 2): R195-202.
 
35. Wills AJ, et al. Refsum's disease. QJM 2001; 94: 403-6.
PubMed
36. Takashima H, et al. A new type of hereditary motor and sensory neuropathy linked to chromosome 3. Ann Neurol 1997; 41: 771-80.
PubMed
37. Umehara F, et al. A novel mutation of desert hedgehog in a patient with 46, XY partial gonadal dysgenesis accompanied by minifascicular neuropathy. Am J Hum Genet 2000; 67: 1302-5.
 
38. Moreira MC, et al. The gene mutated in ataxia-oculomotor apraxia 1 encodes the new HIT/Zn-finger protein aprataxin. Nat Genet 2001; 29: 189-93.
 
39. Takashima H, et al. Mutation of TDP1, encoding a topoisomerase I-dependent DNA damage repair enzyme, in spinocerebellar ataxia with axonal neuropathy. Nat Genet 2002; 32: 267-72.
PubMed
40. Bomont P, et al. The gene encoding gigaxonin, a new member of the cytoskeletal BTB/kelch repeat family, is mutated in giant axonal neuropathy. Nat Genet 2000; 26: 370-4.
PubMed
P.155 掲載の参考文献
1. 厚生省特定疾患原発性アミロイドーシス調査研究班(班長平井俊策). 1992年研究報告書. 1993年3月.
 
2. Kyle RA, Dyck PJ. Amyloidosis and neuropathy. In: Dyck PJ, et al, editors. Peripheral Neuropathy. Philadelphia: WB Saunders; 1993: 1294-309.
 
3. Koike H, et al. Type I(transthyretin Met30)familial amyloidosis polyneuropathy in Japan: Early vs. late-onset form. Arch Neurol 2002; 59(11): 1771-6.
PubMed
P.157 掲載の参考文献
1. Albers JW, et al. Porphyric neuropathy. Muscle Nerve 2004; 30: 410-22.
PubMed
P.160 掲載の参考文献
1. Berger J, et al. Occurrence, distribution, and phenotype of arylsulfatase A mutations in patients with metachromatic leukodystrophy. Am J Med Genet 1997; 69: 335-40.
PubMed
2. Wenger DA, et al. Molecular genetics of Krabbe disease(globoid cell leukodystrophy): Diagnostic and clinical implications. Hum Mutat 1997; 10: 268-79.
PubMed
3. Clarke JT, et al. Enzyme replacement therapy of Fabry disease. Mol Neurobiol 2005; 32: 43-50.
PubMed
P.163 掲載の参考文献
1. Sharp D, et al. Cloning and gene defects in microsomal triglyceride transfer protein associated with abetalipoproteinaemia. Nature 1993; 365: 65-9.
PubMed
2. Nofer JR, et al. Tangier disease: Still more questions than answers. Cell Mol Life Sci 2005; 62: 2150-60.
PubMed
3. Chen W, et al. Genetic analysis enables definite and rapid diagnosis of cerebrotendinous xanthomatosis. Neurology 1998; 51: 865-7
 
P.165 掲載の参考文献
1. 西澤正豊. 劣性遺伝性脊髄小脳変性症. Clin Neurosci 2005; 23: 1434-5.
 
2. Le Ber I, et al. Cerebellar ataxia with oculomotor apraxia type 1: Clinical and genetic studies. Brain 2003; 126: 2761-72.
PubMed
3. Dunn HG. Nerve conduction studies in children with Friedreich's ataxia and ataxia-telangiectasia. Dev Med Child Neurol 1973; 15: 324-37.
PubMed
4. 丸田恭子ほか. アプラタキシンP206Lホモ接合体の兄弟例-EAOHの臨床的多様性について. 神経内科2004; 60: 520-8.
 
P.166 掲載の参考文献
1. Asbury AK. Hepatic neuropathy. In: Dyck PJ, Thomas PK, editors. Peripheral Neuropathy. 3rd ed. Philadelphia: WB Saunders; 1993. p.1257-9.
 
2. Duyff RF, et al. Neuromuscular findings in thyroid dysfunction: A prospective clinical and electrodiagnostic study. J Neurol Neurosurg Psychiatry 2000; 68: 750-5.
PubMed
P.177 掲載の参考文献
1. Yuki N. Carbohydrate mimicry: A new paradigm of autoimmune diseases. Curr Opin Immunol 2005; 17: 577-82.
PubMed
2. Asbury AK, Cornblath DR. Assessment of current diagnostic criteria for Guillain-Barre syndrome. Ann Neurol 1990; 27(Suppl): S21-4.
 
3. 木元一仁ほか. Guillain-Barre 症候群と Fisher 症候群の初診から治療までの経緯. 臨床神経2004; 44: 630-2.
 
4. Fisher M. An unusual variant of acute idiopathic polyneuritis: Syndrome of ophthalmoplegia, ataxia and areflexia. N Engl J Med 1956; 255: 57-65.
PubMed
5. 伊藤雅史ほか. Fisher 症候群の臨床像と治療の現況. 臨床神経2005; 45: 514-7.
 
6. Joint Task Force of the EFNS and the PNS. European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society. J Peripher Nerv Syst 2005; 10: 220-8.
 
7. Odaka M, et al. Intractable chronic inflammatory demyelinating polyneuropathy treated successfully with ciclosporin. J Neurol Neurosurg Psychiatry 2005; 76: 1115-20.
PubMed
8. Kuwabara S, et al. Long term prognosis of chronic inflammatory demyelinating polyneuropathy: A five year follow up of 38 cases. J Neurol Neurosurg Psychiatry 2006; 77: 66-70.
 
9. Nobile-Orazio E, et al. Multifocal motor neuropathy: Current concepts and controversies. Muscle Nerve 2005; 31: 663-80.
PubMed
10. Joint Task Force of the EFNS and the PNS. European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of multifocal motor neuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society. J Peripher Nerv Syst 2006; 11: 1-8.
PubMed
P.186 掲載の参考文献
1. 松田 誠. 高木兼寛とビタミン. 東京慈恵会医科大学雑誌2004; 119: 177-88.
 
2. Schaumburg HH, et al. Disorders of Peripheral Nerves. 2nd ed. Philadelphia: FA DAVIS: 1992. p.116-25.
 
3. Victor M, et al. The Wernicke-Korsakoff Syndrome. 2nd ed. Philadelphia: Davis; 1989.
 
4. 遠藤昌夫. TPN管理下でのビタミンB1欠乏症. そのエビデンス, 頻度, 診断と治療. 医学のあゆみ2004; 209: 257-62.
 
5. 山本悌司. アルコールによる神経疾患とその発症機序. 医学のあゆみ 別冊 神経疾患. 東京: 医歯薬出版; 1999. p.381-5.
 
6. Koike H, et al. Alcoholic neuropathy is clinicopathologically distinct from thiamine-deficiency neuropathy. Ann Neurol 2003; 54: 19-29.
 
7. Yamamoto T. Alcoholic and non-alcoholic Wernicke's encephalopathy. Be alert to the preventable and treatable disease. Intern Med 1996; 35: 754-5.
 
8. Hauw J-J, et al. Chromatolysis in alcoholic encephalopathies. Brain 1988; 111: 843-57.
PubMed
9. Schaumburg HH, et al. Sensory neuropathy from pyridoxine abuse. A new megavitamin syndrome. N Engl J Med 1983; 309: 445-8.
 
10. Brush MG, et al. Pyridoxine in the treatment of premenstrual syndrome: A retrospective survey in 630 patients. Br J Clin Pract 1988; 42: 448-52.
PubMed
11. Russel RM. ビタミンと微量ミネラルの欠乏症と過剰症. ハリソン内科学. 第2版. 東京: メディカル・サイエンス・インターナショナル; 2005. p.631-3.
 
12. Windebank AJ. Polyneuropathy due to nutritional deficiency and alcoholism. In: Dyck PJ, Thomas PK, editors. Peripheral Neuropathy. 3rd ed. Philadelphia: WB Saunders; 1993. p.1310-21.
 
13. 永石彰子ほか. 血清vitamin B12値正常の亜急性連合変性症の1例. 臨床神経2003; 43: 552-5.
 
14. 中島健二. 欠乏性神経疾患. 井村裕夫ほか編. 最新内科学大系 第69巻 代謝性・中毒性神経疾患. 東京: 中山書店; 1996. p.187-96.
 
P.189 掲載の参考文献
1. 大西晃生. 中毒性ニューロパチー. 亀山正邦ほか編. 今日の神経疾患治療指針. 東京: 医学書院; 1994. p.727-30.
 
2. 森若文雄, 田代邦雄. 微量元素と神経系. 神経学的症候. Clin Neurosci 1994; 12: 174-7.
 
3. 額田 均. 中毒性ニューロパチー. 小林祥泰, 水澤英洋編. 神経疾患最近の治療2006-2008. 東京: 南江堂; 2006. p.233-5.
 
4. Windebank AJ. Metal neuropathy. In: Dyck PJ, et al, editors. Peripheral Neuropathy. 4th ed. Philadelphia: Elsevier Saunders; 2005. p.2527-51.
 
5. 井上尚英. 重金属による中毒, 有機水銀中毒. 日野原重明, 井村裕夫監. 看護のための最新医学講座. 第2版. 1脳・神経系疾患. 東京: 中山書店; 2005. p.504-8.
 
P.190 掲載の参考文献
1. 祖父江逸郎ほか. スモン研究の経緯とその解析. 厚生省特定疾患スモン調査研究班 昭和59年度研究業績別冊. 東京: 医歯薬出版; 1985. p.1-327.
 
2. 井形昭弘. スモン. 内科-100年のあゆみ(神経). II. 日本人の貢献. 日内会誌2002; 91: 2302-3.
 
3. 豊倉康夫. 序章 難病の研究. 冲中重雄編. 難病-研究と展望-. 東京: 東京大学出版会; 1979. p.3-4.
 
4. 安藤一也. スモンの神経症候と脊髄病変. 脊椎脊髄1990; 3: 505-11.
 
5. 小長谷正明ほか. スモンの現状-キノホルム禁止後三十二年の臨床分析. 日本医事新報2003; 4137: 21-6.
 
P.193 掲載の参考文献
1. 井上尚英. 重金属による中毒, 有機水銀中毒. 日野原重明, 井村裕夫監. 看護のための最新医学講座. 第2版. 1脳・神経系疾患. 東京: 中山書店; 2005. p.504-8.
 
2. 額田 均. 中毒性ニューロパチー. 小林祥泰, 水澤英洋編. 神経疾患最近の治療2006-2008. 東京: 南江堂; 2006. p.233-5.
 
3. Berger AR, Schaumburg HH. Human toxic neuropathy caused by industrial agents. In: Dyck PJ, et al, editors. Peripheral Neuropathy. 4th ed. Philadelphia: Elsevier Saunders; 2005. p.2505-25.
 
4. Herskovitz S, Schaumburg HH. Neuropathy caused by drugs. In: Dyck PJ, et al, editors. Peripheral Neuropathy. 4th ed. Philadelphia: Elsevier Saunders; 2005. p.2553-83.
 
5. 馬場正之. 薬剤性ニューロパチー. 小林祥泰, 水澤英洋編. 神経疾患最近の治療2006-2008. 東京: 南江堂; 2006. p.226-8.
 
6. 清水 潤. 薬物によるニューロパチー. 田村 晃ほか編. EBMに基づく脳神経疾患の基本的治療指針. 東京: メジカルビュー社; 2006. p.485-9.
 
P.196 掲載の参考文献
1. Lanzillo B, et al. Subclinical peripheral nerve involvement in patients with rheumatoid arthritis. Arthritis Rheum 1998; 41: 1196-202.
PubMed
2. Agard C, et al. Microscopic polyangiitis and polyarteritis nodosa: How and when do they start? Arthritis Rheum 2003; 49: 709-15.
PubMed
3. Hagen NA, et al. Trigeminal sensory neuropathy associated with connective tissue diseases. Neurology 1990; 40: 891-6.
PubMed
4. Said G, Lacroix C. Primary and secondary vasculitic neuropathy. J Neurol 2005; 252: 633-41.
PubMed
5. Mori K, et al. The wide spectrum of clinical manifestations in Sjogren's syndrome-associated neuropathy. Brain 2005; 128: 2518-34.
PubMed
6. Martinez-Taboada VM, et al. Mononeuritis multiplex in systemic lupus erythematosus: Response to pulse intravenous cyclophosphamide. Lupus 1996; 5: 74-6.
PubMed
P.198 掲載の参考文献
1. Sekikawa A, et al. Prevalence of type 2 diabetes mellitus and impaired glucose tolerance in a rural area of Japan. The Funagata diabetes study. J Diabetes Complications 2000; 14: 78-83.
 
2. 馬場正之. 糖尿病に伴う神経障害: ポリニューロパチー. 日内会誌2004; 93: 1556-62.
 
3. 加藤丈夫ほか. 糖尿病に伴う神経障害の診療. 日内会誌2004; 93: 1597-614.
 
4. 岡本幸市. 糖尿病に伴う神経障害: 脳神経障害. 日内会誌2004; 93: 1551-5.
 
5. 日下博文. 糖尿病に伴う神経障害: 糖尿病性筋萎縮症. 日内会誌2004; 93: 1563-6.
 
6. Feldman EL, et al. A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy. Diabetes Care 1994; 17: 1281-9.
PubMed
7. 加藤丈夫. 多発ニューロパチー. 山口 徹ほか編. 今日の治療指針2006年版. 東京: 医学書院; 2006. p.660-1
 
P.200 掲載の参考文献
1. Brouns R, De Deyn Pp.Neurological complications in renal failure: A review. Clin Neurol Neurosurg 2004; 107: 1-16.
PubMed
2. 岡安裕之. 尿毒症性ニューロパチー, 尿毒症性脳症. 神経症候群V. 大阪: 日本臨牀社; 2000. p.558-62.
 
3. Krishnan AV, et al. Altered motor nerve excitability in end-stage kidney disease. Brain 2005; 128: 2164-74.
PubMed
4. 下条文武. 手根管症候群. 腎臓症候群(下). 大阪: 日本臨牀社; 1997. p.36-8.
 
5. Gejyo F, et al. Serum levels of β2-microglobulin as a new form of amyloid protein in patients undergoing long-term hemodialysis. N Eng J Med 1986; 314: 585-6.
 
P.202 掲載の参考文献
1. 蓑田清次. 結節性多発動脈炎と顕微鏡的多発血管炎. 神経症候群IV. 大阪: 日本臨牀社; 2000. p.286-9.
 
2. 服部直樹, 祖父江元. 結節性動脈炎とニューロパチー. 神経内科1999; 51: 329-36.
 
3. 原 元彦. Schurg-Strauss 症候群とニューロパチー. 神経内科1999; 51: 323-8.
 
4. 北川泰久. Wegener 肉芽腫症. 神経症候群IV. 大阪: 日本臨牀社; 2000. p.296-8.
 
5. Fortin PR, et al. Prognosis factors in systemic necrotizing vasculitis of the polyarteritis nodosa group.A review of 45 cases. J Rheumatol 1995; 22: 78-84.
 
P.204 掲載の参考文献
1. 永沢 光ほか. 外転神経麻痺にて発症し, 海綿静脈洞に病変を認めたサルコイドーシス. 臨床神経2005; 45: 38-40.
 
2. Said G, Lacroix C. Primary and secondary vasculitic neuropathy. J Neurol 2005; 252: 633-41.
PubMed
3. Said G, et al. Nerve granulomas and vasculitis in sarcoid peripheral neuropathy: A clinicopathological study of 11 patients. Brain 2002; 125: 264-75.
PubMed
4. de Groot K, et al. Standardized neurologic evaluations of 128 patients with Wegener granulomatosis. Arch Neurol 2001; 58: 1215-21.
PubMed
5. 橋本博史. 難治性血管炎の診療マニュアル. 厚生科学研究特定疾患対策研究事業 難治性血管炎に関する調査研究班. 2002. p.30-4.
 
P.205 掲載の参考文献
1. Churg J, et al. Allergic granulomatosis, allergic angitis, and periarteritis nodosa. Am J Pathol 1951; 27: 277-301.
 
2. Wichman A, et al. Peripheral neuropathy in hypereosinophilic syndrome. Neurology 1985; 35: 1140-5.
PubMed
3. Noth I, et al. Churg-Strauss syndrome. Lancet 2003; 361: 587-94.
PubMed
4. 吉尾 卓. アレルギー性肉芽腫性血管炎. 別冊日本臨牀 領域別症候群シリーズNo.29 神経症候群IV. 大阪: 日本臨牀社; 2000. p.290-3.
 
5. Hattori N, et al. Clinicopathological features of Churg-Strauss syndrome-associated neuropathy. Brain 1999; 122: 427-39.
PubMed
6. 長澤俊彦ほか. アレルギー性肉芽腫性血管炎の本邦症例の臨床像と臨床診断基準の提唱. 日内会誌1989; 78: 352-6.
 
7. 原 元彦. Churg-Strauss症候群とニューロパチー. 神経内科1999; 51: 323-8.
 
P.212 掲載の参考文献
1. 廣瀬源二郎. 悪性腫瘍に伴う神経・筋疾患-神経症状を中心に. 日内会誌2000; 89: 79-84.
 
2. Croft PB, Wilkinson M. The incidence of carcinomatous neuro-myopathy in patients with various types of carcinoma. Brain 1965; 88: 427-34.
 
3. Denny-Brown D. Primary sensory neuropathy with muscular changes associated with carcinoma. J Neurol Neurosurg Psychiatry 1948; 11: 73-87.
PubMed
4. Sakai K, et al. A hippocampal protein associated with paraneoplastic neurologic syndrome and small cell lung carcinoma. Biochem Biophys Res Comm 1994; 199: 1200-8.
PubMed
5. Darnell RB, Posner JB. Paraneoplastic syndromes involving the nervous system. N Engl J Med 2003; 349: 1543-54.
PubMed
6. Bardwick PA, et al. Plasma cell dyscrasia with polyneuropathy, organomegaly, endocrinopathy, M protein and skin changes: The POEMS syndrome. Report on two cases and a review of the literature. Medicine 1980; 59: 311-20.
 
7. Crow R. Peripheral neuritis in myelomatosis. Br Med J 1956; 2: 802-4.
PubMed
8. Fukase M, et al. Report of a case of solitary plasmacytoma in the abdomen presenting polyneuropathy and endocrinological disorders. (Abstract). Clin Neurol(Tokyo)1969; 9: 657.
 
9. Dispenzieri A, et al. POEMS syndrome(Osteosclerotic myeloma). In: Dyck PJ, et al, editors. Peripheral Neuropathy. 4th ed. Vol. 2. Philadelphia: Elsevier Saunders; 2005. p.2453-69.
 
10. Watanabe O, et al. Greatly raised vascular endothelial growth factor(VEGF)in POEMS syndrome. Lancet 1996; 347: 702.
PubMed
11. Miralles GD, et al. Plasma-cell dyscrasia with polyneuropathy. The spectrum of POEMS syndrome. N Engl J Med 1992; 327: 1919-23.
PubMed
12. Umehara F, et al. An autopsied case of the Crow-Fukase syndrome: A neuropathological study with emphasis on spinal roots. Acta Neuropathol 1990; 80: 563-7.
PubMed
13. Sobue G, et al. Extensive demyelinating changes in the peripheral nerves of Crow-Fukase syndrome: A pathological study of one autopsied case. Acta Neuropathol 1992; 84: 171-7.
PubMed
14. Dispenzieri A, et al. POEMS syndrome: Definitions and long-term outcome. Blood 2003; 101: 2496-506.
PubMed
15. Kuwabara S, et al. Autologous peripheral blood stem cell transplantation for POEMS syndrome. Neurology 2006; 66: 105-7.
PubMed
16. Silverstein A, Doniger DE. Neurologic complication of myelomatosis. Arch Neurol 1963; 9: 534-44.
PubMed
17. Latov N, et al. Plasma-cell dyscrasia and peripheral neuropathy with a monoclonal antibody to peripheral-nerve myelin. N Engl J Med 1980; 303: 618-21.
PubMed
18. Longo DL, Anderson KC. Plasma cell disorders. In: Kasper DL, et al, editors. Harrison's Principles of Internal Medicine. 16th ed. Vol 1. New York: McGraw-Hill; 2005. p.656-62.
 
19. Walsh JC. The neuropathy of multiple myeloma. An electrophysiological and histological study. Arch Neurol 1971; 25: 404-14.
PubMed
20. Kyle RA, Dyck PJ. Neuropathy associated with the monoclonal gammopathies. In: Dyck PJ, et al, editors. Peripheral Neuropathy. 4th ed. Vol 2. Philadelphia: Elsevier Saunders; 2005. p.2255-76.
 
P.219 掲載の参考文献
1. 安田 斎, 木建直哉. 癩菌. 日本臨牀別冊 領域別症候群シリーズNo. 26 神経症候群I. 大阪: 日本臨牀社; 1999. p.600-3.
 
2. Agrawal A, et al. Neurologic manifestations of Hansen's disease and their management. Review. Clin Neurol Neurosurg 2005; 107: 445-54.
PubMed
3. 中山聡子ほか. 急性発症の疼痛をともなった上肢多発性単神経炎型ハンセン病ニューロパチーの1例. 臨床神経2003; 43: 265-9.
 
4. 宮田一秀, 岩田 誠. ボレリア. 日本臨牀別冊 領域別症候群シリーズNo. 26 神経症候群I. 大阪: 日本臨牀社; 1999. p.623-8.
 
5. Berglund J, et al. 5-year follow-up study of patients with neuroborreliosis. Scand J Infect Dis 2002; 34: 421-5.
 
6. Pfister H-W, Rupprecht TA. Clinical aspects of neuroborreliosis and post-Lyme disease syndrome in adult patients. Int J Med Microbiol 2006; 296: S1, 11-6.
 
7. Belman AL, et al. Neurologic manifestations in children with North American Lyme disease. Neurology 1993; 43: 2609-14.
PubMed
8. 廣瀬源二郎. ジフテリア菌. 日本臨牀別冊 領域別症候群シリーズNo. 26 神経症候群I. 大 阪: 日本臨牀社; 1999. p.575-7.
 
9. Logina I, Donaghy M. Diphtheric polyneuropathy: A clinical study and comparison with Guillain-Barre syndrome. J Neurol Neurosurg Psychiatry 1999; 67: 433-8.
PubMed
10. Ferrari S, et al. Human immunodeficiency virus-associated peripheral neuropathy. Mayo Clin Proc 2006; 81: 213-9.
PubMed
11. 庄司紘史. 水痘・帯状疱疹ウイルス. ジフテリア菌. 日本臨牀別冊 領域別症候群シリーズNo. 26 神経症候群I. 大阪: 日本臨牀社; 1999. p.425-8.
 
12. Nogueira RG, Traynor B. The neurology of varicella-zoster virus. Arch Neurol 2004; 61: 1974-7.
PubMed
P.222 掲載の参考文献
1. Parsonage MJ, Turner JW. Neuralgic amyotrophy. The shoulder girdle syndrome. Lancet 1948; June 26: 973-8.
 
2. Turner JW, Parsonage MJ. Neuralgic amyotrophy(paralytic brachial neuritis)with special reference to prognosis. Lancet 1957; August 3: 209-12.
 
3. Wilbourn AJ. Neuralgic amyotrophy. In: Dyck P, et al, editors. Peripheral Neuropathy. 3rd ed. Philadelphia: Saunders; 1993. p.933-4.
 
4. Tsairis P, et al. Natural history of brachial plexus neuropathy. Arch Neurol 1972; 27: 109-17.
PubMed
5. Beghi E, et al. Brachial plexus neuropathy in the population of Rochester, Minnesota. Ann Neurol 1985; 18: 320-3.
PubMed
6. McCarty EC, et al. Brachial neuritis. Clin Orthp 1999; 363: 37-43.
 
7. Fibuch EE, et al. Postoperative onset of idiopathic brachial neuritis. Anesthesiology 1996; 84(2): 455-8.
PubMed
8. 立花新太郎ほか. Neuralgic amyotrophy. 別冊整形外科1984; 6: 217-22.
 
9. 麻田善之ほか. Neuralgic amyotrophy による前・後骨間神経麻痺の臨床的検討. 日肘会誌2001; 8: 35-6.
 
10. Helms CA, et al. Acute brachial neuritis(Parsonage-Turner syndrome): MR imaging appearance-Report of three cases. Radiology 1998; 207: 255-9.
PubMed
P.225 掲載の参考文献
1. Stoll BA, Andrew JT. Radiation-induced peripheral neuropathy. Br Med J 1966; 1: 834-937.
 
2. Olsen NK, et al. Radiation-induced brachial plexopathy: Neurological follow-up in 161 recurrence-free breast cancer patients. Int J Radiat Oncol Biol Phys 1993; 26: 43-9.
PubMed
3. Lundborg G, Schildt B. Microvascular permeability in irradiated rabbits. Acta Radiol 1971; 10: 311-2.
PubMed
4. Cavanagh JB. Effect of X-irradiation on the proliferation of cells in peripheral nerve during Wallerian degeneration in the rat. Br J Radiol 1968; 42: 275-81.
 
5. Foley KM, et al. Radiation-induced malignant and atypical peripheral nerve sheath tumors. Ann Neurol 1980; 7: 311-8.
PubMed
6. 法化図陽一ほか. 乳癌転移巣への放射線治療によりradiation neuropathyを発症した1例. 臨床神経学1995; 35: 215-7.
 
P.227 掲載の参考文献
1. Bolton CF, et al. Polyneuropathy in critically ill patients. J Neurol Neurosurg Psychiatry 1984; 47: 1223-31.
PubMed
2. 畑中裕己ほか. Critical illness polyneuropathy(CIP). Annual Review 神経2002; 2002: 244-50.
 
3. Hund E. Critical illness polyneuropathy. Curr Opin Neurol 2001; 14: 649-53.
PubMed
4. Hund E, et al. Critical illness polyneuropathy: Clinical findings and outcomes of a frequent cause of neuromuscular weaning failure. Crit Care Med 1996; 24: 1328-33.
PubMed
5. Bolton CF, et al. Sepsis and the systemic inflammatory response syndrome: Neuromuscular manifestations. Crit Care Med 1996; 24: 1408-16.
PubMed
6. Bolton CF, et al. Critical illness polyneuropathy. Curr Treat Options Neurol 2000; 2: 489-98.
PubMed
7. Mohr M, et al. Effects of early treatment with immunoglobulin on critical illness polyneuropathy following multiple organ failure and Gram-negative sepsis. Intensive Care Med 1997; 23: 1144-9.
PubMed
8. Leijten FSS, et al. The role of polyneuropathy in motor convalescence after prolonged mechanical ventilation. JAMA 1995; 274: 1221-5.
 
9. Zifko UA. Long-term outcome of critical illness polyneuropathy. Muscle Nerve Suppl 2000; 9: S49-52.
PubMed

6章 筋疾患の基礎

P.236 掲載の参考文献
1. 飯野正光. 筋肉とその収縮. 小澤瀞司ほか編. 標準生理学第6版. 東京: 医学書院; 2005. p.107-27.
 
2. 埜中征哉. 臨床のための筋病理. 第3版増補. 東京: 日本医事新報社; 2005.
 
3. Block BA, et al. Structural evidence for direct interaction between the molecular components of the transverse tubule and sarcoplasmic reticulum junction in skeletal muscle. J Cell Biol 1988; 107: 2587-600.
PubMed
4. 工藤典雄. 筋と運動ニューロン. 小澤瀞司ほか編. 標準生理学. 第6版. 東京: 医学書院; 2005. p.322-5.
 
5. Dalakas MC. Diseases of muscle and neuromuscular junction. In: Dale DC, editor. ACP Medicine. New York: WebMD; 2006.
 
6. Jurkat-Rott K, et al. Genetics and pathogenesis of malignant hyperthermia. Muscle Nerve 2000; 23: 4-17.
PubMed
7. 尾方克久. 悪性高熱症とセントラルコア病. リアノジン受容体チャネロパチー. 神経研究の進歩2003; 47: 305-14.
 
P.243 掲載の参考文献
1. Nonaka I, et al. Pathophysiology of muscle fiber necrosis induced by bupivacaine hydrochloride(Marcaine). Acta Neuropathol(Berl)1983; 60: 167-74.
PubMed
2. Ownby CL, et al. Cardiotoxin 1 from cobra(Naja naja atra)venom causes necrosis of skeletal muscle in vivo. Toxicon 1993; 31: 697-709.
PubMed
3. Ishiura S, et al. Biochemical aspects of bupivacaine-induced acute muscle degradation. J Cell Sci 1986; 83: 197-212.
PubMed
4. Sorimachi H, et al. Skeletal muscle-specific calpain, p94, and connectin/titin: Their physiological functions and relationship to limb-girdle muscular dystrophy type 2A. Adv Exp Med Biol 2000; 481: 383-95.
PubMed
5. Nagano A, et al. Emerin deficiency at the nuclear membrane in patients with Emery-Dreifuss muscular dystrophy. Nat Genet 1996; 12: 254-9.
PubMed
6. Gillard EF, et al. A substitution of cysteine for arginine 614 in the ryanodine receptor is potentially causative of human malignant hyperthermia. Genomics 1991; 11: 751-5.
PubMed
7. Ibarra MCA. Malignant hyperthermia in Japan: Mutation screening of the entire ryanodine receptor type 1 gene coding region by direct sequencing. Anesthesiology 2006; 104: 1146-54.
 
8. Robinson R, et al. Mutations in RYR1 in malignant hyperthermia and central core disease. Hum Mutat 2006; 27: 977-89.
PubMed
9. Wu S, et al. Central core disease is due to RYR1 mutations in more than 90% of patients. Brain 2006; 129: 1470-80.
PubMed
10. Wappler F, et al. Pathophysiological role of the serotonin system in malignant hyperthermia. Br J Anaesth 2001; 87: 794-8.
PubMed
11. Christopher-Stine L. Statin myopathy: An update. Curr Opin Rheumatol 2006; 18: 647-53.
PubMed
12. Nonaka I. Distal myopathies. Curr Opin Neurol 1999; 12: 493-9.
PubMed
13. Yan C, et al. Distal myopathies. Curr Opin Neurol 1999; 12: 493-9.
 
14. Askanas V, Engel WK. Newest pathogenetic considerations in inclusion-body myositis: Possible role of amyloid-beta, cholesterol, relation to aging and to Alzheimer's disease. Curr Rheumatol Rep 2002; 4: 427-33.
PubMed
15. 埜中征哉. 臨床のための筋病理. 第3版. 東京: 日本医事新報社; 1999.
 
16. Hirata A, et al. Expression profiling of cytokines and related genes in regenerating skeletal muscle after cardiotoxin injection: A role for osteopontin. Am J Pathol 2003; 163: 203-15.
PubMed
17. Jin Y, et al. Expression of MyoD and myogenin in dystrophic mice, mdx and dy, during regeneration. Acta Neuropathol(Berl)2000; 99: 619-27.
PubMed
18. Ehrhardt J, Morgan J. Regenerative capacity of skeletal muscle. Curr Opin Neurol 2005; 18: 548-53.
PubMed
19. Ferrati G, et al. Muscle regeneration by bone marrow-derived myogenic progenitors. Science 1998; 279: 1528-30.
 
20. Dezawa M, et al. Bone marrow stromal cells generate muscle cells and repair muscle degeneration. Science 2005; 309: 314-7.
PubMed

7章 筋疾患の診察・診断

P.249 掲載の参考文献
1. 上坂義和. 神経・筋疾患の症候と診断の進め方. 病理と臨床1993; 11: 1252-5.
 
2. 岩田 誠. 神経症候学を学ぶ人のために. 東京: 医学書院; 1994.
 
3. 川井 充. ニューロパチーとミオパチーはどのような病気か. medicina 1999; 36: 1250-1.
 
4. 村山繁雄. ニューロパチーとミオパチー 患者の訴えと病歴のとりかた 病歴で何がどこまでわかるか. medicina 1999; 36: 1252-3.
 
5. 栗原照幸. 筋情報の収集テクニック. Clinical Neuroscience 2003; 21: 278-81.
 
6. Banwell BL, Gomez MR. The clinical examination. In: Engel AG, Franzini-Armstrong C, editors. Myology. 3rd ed. New York: McGraw Hill; 2004. p.599-617.
 
7. 埜中征哉. 筋疾患の子供の診かた, 考え方. 小児科診療2006; 69: 473-9.
 
8. 川井 充. 神経疾患における患者の訴え. 診断と治療2005; 93: 1196-200.
 
9. Hislop HJ, Montgomery J(津山直一訳). 新・徒手筋力検査法. 原著第7版. 東京: 協同医書出版社; 2003.
 
10. Kendall FP, et al. Muscles: Testing and Function with Posture and Pain. 5th ed. New York: Lippincott Williams & Wilkins; 2005.
 
11. Medical Research Council of the United Kingdom. Aids to the Examination of the Peripheral Nervous System. London: Pendragon House; 1978.
 
12. Masur H, et al. Scales and Scores in Neurology. Stuttgart: Thieme; 2004. p.54-6.
 
13. 尾方克久. ニューロパチーとミオパチー神経筋以外の臓器の診かた. medicina 1999; 36: 1271-4.
 
P.254 掲載の参考文献
1. 園生雅弘. 針筋電図によるレベル診断. 園生雅弘ほか編. 神経筋電気診断の実際. 東京: 星和書店; 2004. p.77-84.
 
2. 園生雅弘. 筋電図と筋病理. 病理と臨床1993; 11: 1256-61.
 
3. 園生雅弘. 筋電図検査とミオパチーの診断. Clinical Neuroscience 1999; 17: 1107-10.
 
4. 園生雅弘. 筋原性疾患の筋電図診断. 臨床神経生理学2001; 29: 228-36.
 
5. 園生雅弘. 筋疾患の電気生理学的検査. 臨床検査2002; 46: 523-9.
 
6. 長谷川修. 反復刺激試験. 神経筋電気診断の実際. 園生雅弘ほか編. 神経筋電気診断の実際. 東京: 星和書店; 2004. p.53-9.
 
7. 木村 淳, 幸原伸夫. 単一線維筋電図. 神経伝導検査と筋電図を学ぶ人のために. 東京: 医学書院; 2003. p.205-13.
 
8. Gilchrist JM, et al. Single fiber EMG and repetitive stimulation of the same muscle in myasthenia gravis. Muscle Nerve 1994; 17: 171-5.
PubMed
P.257 掲載の参考文献
1. 川井 充. 筋疾患の画像診断. 病理と臨床1993; 11: 1311-20.
 
2. Marianne de Visser, et al. Muscle imaging. In: Engel A, et al, editors. Myology. 3rd ed. New York: McGraw-Hill; 2004.
 
3. 河野 智ほか. 超音波による fasciculation の画像診断. 臨床神経1998; 38: 259-62.
 
P.261 掲載の参考文献
1. 大矢 寧ほか. 筋ジストロフィーでの血清AST/ALT 比の高値. 第47回日本神経学会総会. 2006.
 
2. Neuromuscular Disorders: Gene location. Neuromuscular Disord 2006; 16: 64-90.
PubMed
3. Engel AG, et al. Muscular dystrophies. In: Engel AG, et al, editors. Myology. 3rd ed. New York: McGraw-Hill; 2004.
 
4. Chamberlain JS, et al. Duchenne Muscular Dystrophy. New York: Taylor & Francis; 2006. p.91-104.
 
P.266 掲載の参考文献
1. 川井 充. 筋生検法. 病理と臨床1993; 11: 1262-9.
 
2. 埜中征哉. 臨床のための筋病理. 第3版. 東京: 日本医事新報社; 1999.
 

8章 筋疾患各論

P.271 掲載の参考文献
1. ALS治療ガイドライン作成小委員会. ALS治療ガイドライン. 臨床神経2002; 42: 678-719.
 
2. Rosen DR, et al. Mutations in Cu/Zn-superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 1993; 362: 59-62.
PubMed
3. Bruijn LI, et al. Unraveling the mechanisms involved in motor neuron degeneration in ALS. Annu Rev Neurosci 2004; 27: 723-49.
PubMed
4. 佐々木彰一. ALSの亜系. 臨床神経2006; 46: 825-7.
 
5. 加藤信介ほか. ALS運動ニューロンの細胞病理. 神経研究の進歩2004; 48: 457-368.
 
6. Neumann M, et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 2006; 314: 130-3.
 
7. World Federation of Neurology Research Group on Neuromuscular Diseases. World Federation of Neurology criteria for diagnosis of amyotrophic lateral sclerosis. J Neurol Sci 1994; 124(Suppl): 96-107.
 
8. Traynor BJ, et al. Clinical features of amyotrophic lateral sclerosis according to the El Escorial and Airlie House diagnostic criteria. Arch Neurol 2000; 57: 1171-6.
 
P.272 掲載の参考文献
1. Harding AE. Inherited neuronal atrophy and degeneration predominantly of lower motor neurons. In: Dyck PJ, et al, editors. Peripheral Neuropathy. 4th ed. Philadelphia: Elsevier Saunders; 2005. p.1603-21.
 
2. Coovert DD, et al. The survival neuron protein in spinal muscular atrophy. Hum Mol Genet 1997; 6: 1205-14.
PubMed
3. Pearn JH, et al. Genetic identity of acute infantile spinal muscular atrophy. Brain 1973; 96: 463-70.
PubMed
4. Timmermann V, et al. Distal hereditary motor neuropathy type II(distal HMN II): Mapping of a locus to chromosome 12q24. Mol Genet 1995; 5: 1065-9.
 
5. Harding AE, Thomas PK. Hereditary distal spinal muscular atrophy: A report on 34 cases and a review of the literature. J Neurol Sci 1980; 45: 337-42.
 
6. Matsunaga M, et al. Oculopharyngeal involvement in familial neurogenic muscular atrophy. J Neurol Neurosurg Psychiatry 1973; 36: 104-11.
PubMed
P.275 掲載の参考文献
1. Gordon PH, et al. The natural history of primary lateral sclerosis. Neurology 2006; 66: 647-53.
PubMed
2. Swash M, et al. What is primary lateral sclerosis? J Neurol Sci 1999; 170: 5-10.
PubMed
3. Pringle CE, et al. Primary lateral sclerosis. Clinical features, neuropathology and diagnostic criteria. Brain 1992; 115: 495-520.
PubMed
4. Strong MJ, et al. Primary lateral sclerosis, hereditary spastic paraplegia and amyotrophic lateral sclerosis: Discrete entities or spectrum? Amyotroph Lateral Scler Other Motor Neuron Disord 2005; 6: 8-16.
PubMed
5. Rowland LP, et al. Primary lateral sclerosis; Hereditary and acquired spastic paraplegia. In: Rowland LP, editor. Merritt's Neurology. 11th ed. Philadelphia: Lippincott Williams & Wilkins; 2005. p.855-60.
 
6. Russell JA. Primary lateral sclerosis: Motor neuron disease presenting with upper neuron features in the limb. In: Jones HR, editor. Netter's Neurology. 1st ed. Teterboro: Icon Learning Systems LLC; 2005. p.783-8.
 
7. Ulug AM, et al. Diffusion tensor imaging in the diagnosis of primary lateral sclerosis. J Magn Reson Imaging 2004; 19: 34-9.
 
P.277 掲載の参考文献
1. Kennedy WR, et al. Progressive proximal spinal and bulbar muscular atrophy of late onset: A sex-linked recessive trait. Neurology 1968; 18: 671-80.
PubMed
2. Sobue G, et al. X-linked recessive bulbospinal neuronopathy: A clinicopathological study. Brain 1989; 112: 209-32.
PubMed
3. La Spada AR, et al. Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature 1991; 352: 77-9.
 
4. Doyu M, et al. Severity of X-linked recessive bulbospinal neuronopathy correlates with the size of the tandem CAG repeat in androgen receptor gene. Ann Neurol 1992; 32: 707-10.
PubMed
5. 道勇 学ほか. 球脊髄性筋萎縮症(SBMA). 神経研究の進歩1997; 41: 357-66.
 
6. Li M, et al. Nuclear inclusions of the androgen receptor protein in spinal and bulbar muscular atrophy. Ann Neurol 1998; 44: 249-54.
PubMed
7. Katsuno M, et al. Leuprorelin rescues polyglutamine-dependent phenotypes in a transgenic mouse model of spinal and bulbar muscular atrophy. Nature Med 2003; 9: 768-73.
 
8. Banno H, et al. Mutant androgen receptor accumulation in spinal and bulbar muscular atrophy scrotal skin: A pathogenic marker. Ann Neurol 2006; 59: 520-6.
PubMed
P.294 掲載の参考文献
1. Kunkel LM, et al. Diagnosis and cell based therapy for Duchenne muscular dystrophy in humans, mice, and zebrafish. J Hum Genet 2006; 51: 397-406.
PubMed
2. 埜中征哉. 筋ジストロフィー. 臨床のための筋病理. 第3版. 東京: 日本医事新報社; 2005. p.42-75.
 
3. 埜中征哉. 小児神経・筋疾患の臨床症状の診かた. 小児科2005; 46: 24-30.
 
4. Engel AG, Ozawa E. Dystrophinopathies. In: Engel AG, Franzini-Armstrong C, editors. Myology. 3rd ed. New York: McGraw-Hill; 2004. p.961-1025.
 
5. Moxley RT. Clinical overview of Duchenne muscular dystrophy. In: Chambelain JS, Rand TA, editors. Duchenne muscular dystrophy. Advances in therapeutics. New York: Taylor & Francis; 2006. p.1-20.
 
6. Moxley RT, et al. Practice parameter: Corticosteroid treatment of Duchenne dystrophy: Report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology 2005; 64: 13-20.
 
7. 高相晶士ほか. 筋ジストロフィーの骨格変形を測る-脊椎変形と骨盤傾斜を測る. 神経内科2005; 62: 44-50.
 
8. 田村拓久. 筋ジストロフィーの心筋障害の診断と治療. 神経内科2005; 62: 530-8.
 
9. 埜中征哉ほか. 肢帯型筋ジストロフィー研究の進歩. 臨床神経学2001; 41: 1194-7.
 
10. Chae J, et al. Calpain 3 gene mutations: Genetic and clinico-pathologic findings in limb-girdle muscular dystrophy. Neuromuscul Disord 2001; 11: 547-55.
PubMed
11. Liu J, et al. Dysferlin, a novel skeletal muscle gene, is mutated in Miyoshi myopathy and limb girdle muscular dystrophy. Nat Genet 1998; 20: 31-6.
PubMed
12. Takahashi T, et al. Dysferlin mutations in Japanese Miyoshi myopathy: Relationship to phenotype. Neurology 2003; 60: 1799-804.
PubMed
13. Ozawa E, et al. Molecular and cell biology of the sarcoglycan complex. Muscle Nerve 2005; 32: 563-76.
PubMed
14. Ozawa E, et al. From dystrophinopathy to sarcoglycanopathy: Evolution of a concept of muscular dystrophy. Muscle Nerve 1998; 21: 421-38.
PubMed
15. Wijmenga C, et al. Chromosome 4q DNA rearrangements associated with facioscapulohumeral muscular dystrophy. Nat Genet 1992; 2: 26-30.
PubMed
16. Backer E, et al. Diagnostic, predictive, and prenatal testing for facioscapulohumeral muscular dystrophy: Diagnostic approach for sporadic and familial cases. J Med Genet 1996; 33: 29-35.
 
17. 埜中征哉. 先天性筋ジストロフィー研究の進歩. 脳と発達2005; 37: 115-21.
 
18. Kobayashi K, et al. An ancient retrotransposal insertion causes Fukuyama-type congenital muscular dystrophy. Nature 1998; 394: 388-92.
PubMed
19. Hino N, et al. Clinicopathological study on eyes from cases of Fukuyama type congenital muscular dystrophy. Brain Dev 2001; 23: 97-107.
 
20. Hayashi YK, et al. Selective deficiency of alpha-dystroglycan in Fukuyama-type congenital muscular dystrophy. Neurology 2001; 57: 115-21.
PubMed
21. Mercuri E, et al. Congenital muscular dystrophies. Semin Pediatr Neurol 2002; 9: 120-31.
PubMed
22. Endo T, Toda T. Glycosylation in congenital muscular dystrophies. Biol Pharm Bull 2003; 26: 1641-7.
PubMed
23. 戸田達史. 福山型筋ジストロフィー. 小児科診療2006; 69: 517-25.
 
24. Beltran-Valero de Bernabe D, et al. Mutations in the O-mannosyltransferase gene POMT1 give rise to the severe neuronal migration disorder Walker-Warburg syndrome. Am J Hum Genet 2002; 71: 1033-43.
 
25. Yosida Y, et al. Muscular dystrophy and neuronal migration disorder caused by mutations in a glycosyltransferase, POMGnT1. Dev Cell 2001; 1: 717-24.
 
26. Camacho Vanegas O, et al. Ullrich scleroatonic muscular dystrophy is caused by recessive mutations in collagen type VI. Proc Natl Acad Sci USA 2001; 98: 7516-21.
PubMed
27. Higuchi I, et al. Frameshift mutation in the collagen VI gene causes Ullrich's disease. Ann Neurol 2001; 50: 261-5.
 
28. Ishikawa H, et al. Ullrich disease due to deficiency of collagen VI in the sarcolemma. Neurology 2004; 62: 620-3.
PubMed
29. Nonaka I, et al. Clinical and histological study of Ullrich's disease(congenital atonic-sclerotic muscular dystrophy). Neuropediatrics 1981; 12: 197-208.
 
30. Nonaka I, et al. Autosomal recessive distal muscular dystrophy: A comparative study with distal myopathy with rimmed vacuole formation. Ann Neurol 1985; 17: 51-9.
PubMed
31. Eisenberg I, et al. The UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase gene is mutated in recessive hereditary inclusion body myopathy. Nat Genet 2001; 29: 83-7.
PubMed
32. Nonaka I. Distal myopathies. Curr Opin Neurol 1999; 12: 493-9.
PubMed
33. Rankin J, Ellard S. The laminopathies: A clinical review. Clin Genet 2006; 70: 261-74.
PubMed
34. Hayashi YK. X-linked form of Emery-Dreifuss muscular dystrophy. Acta Myol 2005; 24: 98-103.
PubMed
35. Machuca-Tzili L, et al. Clinical and molecular aspects of the myotonic dystrophies: A review. Muscle Nerve 2005; 32: 1-18.
PubMed
36. Harley HG, et al. Expansion of an unstable DNA region and phenotypic variation in myotonic dystrophy. Nature 1992; 355: 545-6.
PubMed
37. Harley HG, et al. Size of the unstable CTG repeat sequence in relation to phenotype and parental transmission in myotonic dystrophy. Am J Hum Genet 1993; 52: 1164-74.
PubMed
38. Machuca-Tzili L, et al. Clinical and molecular aspects of the myotonic dystrophies: A review. Muscle Nerve 2005; 32: 1-18.
PubMed
39. 石浦章一. RNA病としての筋強直性ジストロフィー. 臨床神経学2005; 45: 828-30.
 
40. Linguori CL, et al. Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9. Science 2001; 293: 864-7.
 
P.304 掲載の参考文献
1. Shy GM, et al. Nemaline myopathy. A new congenital myopathy. Brain 1963; 86: 793-810.
PubMed
2. 埜中征哉. ネマリンミオパチーの分子病態. Annual Review 2004. 東京: 中外医学社; 2004. p.279-85.
 
3. Sparrow JC, et al. Muscle disease caused by mutations in the skeletal muscle alpha-actin gene(ACTA1). Neuromuscul Disord 2003; 13: 519-31.
PubMed
4. Wattanasirichaigoon D, et al. Mutations of the slow muscle alpha-tropomyosin gene, TPM3, are a rare cause of nemaline myopathy. Neurology 2002; 59: 613-7.
PubMed
5. Donner K, et al. Mutations in the beta-tropomyosin(TPM2)gene-a rare cause of nemaline myopathy. Neuromuscul Disord 2002; 12: 151-8.
PubMed
6. Johnston JJ, et al. A novel nemaline myopathy in the Amish caused by a mutation in troponin T1. Am J Hum Genet 2000; 67: 814-21.
PubMed
7. Pelin K, et al. Nebulin mutations in autosomal recessive nemaline myopathy: An update. Neuromuscul Disord 2002; 12: 680-6.
PubMed
8. 埜中征哉. 先天性ミオパチー. 埜中征哉著. 臨床のための筋病理. 第3版. 東京: 日本医事新報社; 2005. p.90-106.
 
9. Ryan MM, et al. Nemaline myopathy: A clinical study of 143 cases. Ann Neurol 2001; 50: 312-20.
PubMed
10. Chahin N, et al. Sporadic late onset nemaline myopathy. Neurology 2005; 65: 1158-64.
PubMed
11. Wu S, et al. Central core disease is due to RYR1 mutations in more than 90 % of patients. Brain 2006; 129: 1470-80.
PubMed
12. Ibarra MCA, et al. Malignant hyperthermia in Japan: Mutation screening of the entire ryanodine receptor type 1 gene coding region by direct sequencing. Anesthesiology 2006; 104: 1146-54.
 
13. Robinson R, et al. Mutations in RYR1 in malignant hyperthermia and central core disease. Hum Mutat 2006; 27: 977-89.
PubMed
14. Ferreiro A, et al. Mutations of the selenoprotein N gene, which is implicated in rigid spine muscular dystrophy, cause the classical phenotype of multiminicore disease: Reassessing the nosology of early-onset myopathies. Am J Hum Genet 2002; 71: 739-49.
PubMed
15. Jungbluth H, et al. Minicore myopathy with ophthalmoplegia caused by mutations in the ryanodine receptor type 1 gene. Neurology 2005; 65: 1930-5.
PubMed
16. Ferreiro A, et al. Multi-minicore disease-searching for boundaries: Phenotype analysis of 38 cases. Ann Neurol 2000; 48: 745-57.
PubMed
17. Spiro AJ, et al. Myotubular myopathy. Persistence of fetal muscle in an adolescent boy. Arch Neurol 1966; 14: 1-14.
 
18. Bitoun M, et al. Mutations in dynamin 2 cause dominant centronuclear myopathy. Nat Genet 2005; 37: 1207-9.
PubMed
19. Fischer D, et al. Characterization of the muscle involvement in dynamin 2-related centronuclear myopathy. Brain 2006; 129: 1463-9.
PubMed
20. Laporte J, et al. A gene mutated in X-linked myotubular myopathy defines a new putative tyrosine phosphatase family conserved in yeast. Nat Genet 1996; 13: 175-82.
 
21. Tsai TC, et al. Characterization of MTM1 mutations in 31 Japanese families with myotubular myopathy, including a patient carrying 240 kb deletion in Xq28 without male hypogenitalism. Neuromuscul Disord 2005; 15: 245-52.
PubMed
22. Buj-Bello A, et al. Identification of novel mutations in the MTM1 gene causing severe and mild forms of X-linked myotubular myopathy. Hum Mutat 1999; 14: 320-5.
PubMed
23. McEntagart M, et al. Genotype-phenotype correlations in X-linked myotubular myopathy. Neuromuscul Disord 2002; 12: 939-46.
 
24. Laing NG, et al. Actin mutations are one cause of congenital fibre type disproportion. Ann Neurol 2004; 56: 689-94.
PubMed
25. Clarke NF, et al. SEPN1: Associated with congenital fiber-type disproportion and insulin resistance. Ann Neurol 2006; 59: 546-52.
PubMed
26. Tojo M, et al. Central core disease and congenital neuromuscular disease with uniform type 1 fibers in one family. Brain Dev2000; 22: 262-4.
PubMed
27. Nonaka I, et al. Congenital myopathy without specific features(minimal change myopathy). Neuropediatrics 1983; 14: 237-41.
PubMed
P.318 掲載の参考文献
1. DiMauro S, et al. Mitochondrial myopathies. Ann Neurol 1985; 17: 521-38.
PubMed
2. Kearns TP, Sayre Gp.Retinitis pigmentosa, external ophthalmoplegia and complete heart block. Arch Ophthalmol 1958; 60: 280-9.
PubMed
3. Holt IJ, et al. Deletions of muscle mitochondrial DNA in patients with mitochondrial myopathies. Nature 1988; 331: 717-9.
PubMed
4. Goto Y, et al. Chronic progressive external ophthalmoplegia: A correlative study of mitochondrial DNA deletions and their phenotypic expression in muscle biopsies. J Neurol Sci 1990; 100: 63-9.
PubMed
5. Inoue K, et al. Generation of mice with mitochondrial dysfunction by introducing mouse mtDNA carrying a deletion into zygotes. Nat Genet 2000; 26: 176-81.
PubMed
6. Nakada K, et al. Inter-mitochondrial complementation: Mitochondria-specific system preventing mice from expression of disease phenotypes by mutant mtDNA. Nat Med 2001; 7: 934-40.
PubMed
7. Pavlakis SG, et al. Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke-like episodes: A distinctive clinical syndrome. Ann Neurol 1984; 16: 481-8.
PubMed
8. Goto Y, et al. A mutation in the tRNA-Leu(UUR)gene associated with the MELAS subgroup of mitochondrial encephalomyopathies. Nature 1990; 348: 651-3.
PubMed
9. Fukuhara N, et al. Myoclonus epilepsy associated with ragged-red fibers(mitochondrial abnormalities): Disease entity or a syndrome? J Neurol Sci 1980; 47: 117-33.
 
10. Shoffner JM, et al. Myoclonic epilepsy and ragged-red fiber disease(MERRF)is associated with a mitochondrial DNA tRNALys mutation. Cell 1990; 61: 931-7.
PubMed
11. Leigh D. Subacute necrotizing encephalomyopathy in an infant. J Neurol Neurosurg Psychiatry 1951; 14: 216-21.
 
P.328 掲載の参考文献
1. Dalakas MC, et al. Polymyositis and dermatomyositis. Lancet 2003; 362: 971-82.
PubMed
2. Dalakas MC. Polymyositis, dermatomyositis and inclusion body myositis. N Engl J Med 1991; 325: 1487-98.
PubMed
3. Mastaglia FL, et al. Inflammatory myopathies: Clinical, diagnostic and therapeutic aspects. Muscle Nerve 2003; 27: 407-25.
PubMed
4. Hirakata M, et al. Myositis-specific antibodies are associated with HLA class in alleles in Japanese patients. Arthritis Rheum 1995; 38: S321.
 
5. Hirakata M, Nagai S. Interstitial lung disease in polymyositis and dermatomyositis. Curr Opin Rheumatol 2000; 12: 501-8.
PubMed
6. Nishikai M, Reichlin M. Heterogeneity of precipitating antibodies in polymyositis and dermatomyositis. Characterization of the Jo-1 antibody system. Arthritis Rheum 1980; 23: 881-8.
PubMed
7. Engel AG. The polymyositis and dermatomyositis syndrome. In: Engel AG, Franzini-Armstrong C, editors. Myology. New York: McGraw-Hill; 1994. p.1335-83.
 
8. Kissel JT, et al. Microvascular deposition of complement membrane attack complex in dermatomyositis. N Engl J Med 1986; 314: 329-34.
PubMed
9. 衣斐 達ほか. 多発・皮膚筋炎の生検筋における熱ショック蛋白70の免疫組織学的観察. 臨床神経学1995; 35: 1163-6.
 
10. Orimo S, et al. Immunohistochemical analysis of perforin and granzyme A in inflammatory myopathies. Neuromuscul Disord 1994; 4: 219-26.
PubMed
11. 衣斐達ほか. 病的骨格筋線維における主要組織適合性遺伝子(HLA-A, B, C, HLA-DR)およびintercellular adhesion molecule 1(ICAM-1)の発現. 神経内科1996; 44: 529-36.
 
12. 谷本潔昭ほか. 皮膚筋炎・多発筋炎の改訂診断基準. 厚生省特定疾患自己免疫疾患調査研究班 平成4年度研究報告書. 1993. p.25-8.
 
13. 衣斐達, 佐橋 功. 筋炎の治療. 治療のアルゴリズム. Clinical Neuroscience 2004; 22: 1175-7.
 
14. 秋月正史. 多発筋炎/皮膚筋炎の予後. Clinical Neuroscience 2004; 22: 1172-3.
 
15. Fujikawa S, Okuni M. A nationwide surveillance study of rheumatic diseases among Japanese children. Acta Paediatr Jpn 1997; 39: 242-4.
PubMed
16. Richardson JB, Callen Jp.Dermatomyositis and malignancy. Med Clin North Am 1989; 73: 1211-20.
PubMed
17. 金子佳世子ほか. 皮膚筋炎と悪性腫瘍. 皮膚臨床1985; 27: 499-505.
 
18. Arahata K, et al. Immunohistochemical study of dermatomyositis associated with neoplasia. In: Igata A, editor. Neuroimmunological Diseases; Recent advance in pathogenesis and treatment. Tokyo: University of Tokyo Press; 1988. p.313-9.
 
19. Carpenter S, et al. Inclusion body myositis: A distinct variety of idiopathic inflammatory myopathy. Neurology 1978; 28: 8-17.
PubMed
20. Mikol J, Engel AG. Inclusion body myositis. In: Engel AG, Franzini-Armstrong C, editors. Myology. 2nd ed. New York: McGraw-Hill; 1994. p.1384-98.
 
21. 藤掛彰史, 衣斐達. 自験封入体筋炎に関する臨床および病理的所見の検討. 愛知医大誌2004; 32: 25-32.
 
22. Griggs RC, et al. Inclusion body myositis and myopathies. Ann Neurol 1995; 38: 705-13.
PubMed
23. Askanas V, et al. Twisted tubulofilaments of inclusion body myositis muscle resemble paired helical filaments of Alzheimer brain and contain hyperphosphorylated tau. Am J Pathol 1994; 144: 177-87.
PubMed
24. Dalakas MC, et al. A controlled study of intravenous immunoglobulin combined with prednisone in the treatment of IBM. Neurology 2001; 56: 323-7.
PubMed
25. Banker BQ. Sarcoid myopathy. In: Engel AG, Franzini-Armstrong C, editors. Myology. 2nd ed. New York: McGraw-Hill; 1994. p.1468-70.
 
26. Silverstein A, Siltzbach LE. Muscle involvement in sarcoidosis. Asymptomatic, myositis, and myopathy. Arch Neurol 1969; 21: 235-41.
PubMed
27. Hinterbuchner CN, Hinterbuchner Lp.Myopathic syndrome in muscular sarcoidosis. Brain 1964; 87: 355-66.
PubMed
28. Ishige I, et al. Quantitative PCR of mycobacterial and propionibacterial DNA in lymph nodes of Japanese patients with sarcoidosis. Lancet 1999; 354: 120-3.
PubMed
29. 衣斐達ほか. 筋サルコイド-シスの生検筋におけるMHC および細胞接着分子の免疫組織学的検討. 臨床神経1995; 35: 996-1002.
 
30. Illa I, et al. Immunocytochemical and virological characteristics of HIV-associated inflammatory myopathies: Similarities with seronegative polymyositis. Ann Neurol 1991; 29: 474-81.
PubMed
31. 越智博文, 吉良純一. HTLV-1関連ミオパチー. 別冊日本臨牀 領域別症候群シリーズ35 骨格筋症候群(上). 大阪: 日本臨牀社; 2001. p.198-201.
 
32. 島津岳士, 上尾光弘. クロストリジウム(ガス壊疽菌). 別冊日本臨牀 領域別症候群シリーズ35 骨格筋症候群 (上). 大阪: 日本臨牀社; 2001. p.222-5.
 
33. 河島尚志, 小林楠和. 真菌性筋炎. 別冊日本臨牀 領域別症候群シリーズ35 骨格筋症候群(上). 大阪: 日本臨牀社; 2001. p.243-5.
 
P.331 掲載の参考文献
1. Lehmann-Horn F, et al. Nondystrophic myotonias and periodic paralyses. In: Engel AG, Franzini-Armstrong C, editors. Myology. New York: McGraw-Hill; 2004. p.1258-80.
 
2. Pusch M. Myotonia caused by mutations in the muscle chloride channel gene CLCN1. Hum Mutat 2002; 19: 423-34.
 
3. Colding-Jorgensen E. Phenotypic variability in myotonia congenita. Muscle Nerve 2005; 32: 19-34.
 
4. 岡本幸市, 池田佳生. チャネロパチー. 臨床神経2001; 41: 1226-8.
 
5. 栗原照幸. ミオトニー疾患とチャネロパチー. 日本内科学会雑誌2004; 93: 510-4.
 
6. Cannon SC. From mutation to myotonia in sodium channel disorders. Neuromusc Disord 1997; 7: 241-9.
PubMed
7. Vicart S, et al. Human skeletal muscle sodium channelopathies. Neurol Sci 2005; 26: 194-202.
PubMed
P.335 掲載の参考文献
1. Drachman DB. Myasthenia gravis. N Engl J Med 1994; 330: 1797-810.
PubMed
2. Vincent A. Seronegative myasthenia gravis. Semin Neurol 2004; 24: 125-33.
PubMed
3. Richman DP, et al. Treatment of autoimmune myasthenia gravis. Neurology 2003; 61: 1652-61.
PubMed
4. 田中惠子. 神経・筋疾患 重症筋無力症. 血液浄化療法(上) -基礎理論と最新臨床応用-IV. 慢性血液浄化療法. 日本臨床2004; 62(Suppl 5): 580-5.
 
5. Eaton LM, et al. Electromyography and electric stimulation of nerves in diseases of motor unit: Observations on myasthenic syndrome associated with malignant tumors. J Am Med Assoc 1957; 163: 1117-24.
PubMed
6. 本村政勝ほか. Lambert-Eaton 筋無力症候群-その分子発症機構. 田中正美ほか編. 別冊・医学のあゆみ 21世紀の神経免疫学. 東京: 医歯薬出版; 2001. p.184-9.
 
7. Lang B, et al. Autoimmune aetiology for myasthenic(Eaton-Lambert)syndrome. Lancet 1981; ii: 224-6.
 
8. Motomura M, et al. Incidence of serum anti-P/Q-type and anti-N-type calcium channel autoantibodies in the Lambert-Eaton myasthenic syndrome. J Neurol Sci 1997; 147: 35-42.
 
9. Lennon VA, et al. Calcium-channel antibodies in the Lambert-Eaton syndrome and other paraneoplastic syndromes. N Engl J Med 1995; 332: 1467-74.
PubMed
10. Tim RW, et al. Lambert-Eaton syndrome: Clinical and electrodiagnostic features and response to therapy in 59 patients. Ann NY Acad Sci 1998; 841: 823-6.
PubMed
P.343 掲載の参考文献
1. Ropper AH, Brown RH, editors. The periodic paralysis and hereditary, nondystrophic myotonias(ion channel disorders). In: Adams and Victor's Principles of Neurology. 8th ed. New York: McGraw-Hill; 2005. p.1265-8.
 
2. Rowland LP, Gordon PH. Familial periodic paralysis. In: Rowland LP, editor. Merritt's Neurology. 11th ed. Philadelphia: Lippincott Williams & Wilkins; 2005. p.911-5.
 
3. Barohn RJ. Channelopathies(Nondystrophic myotonias and periodic paralyses). In: Goldman L, Ausiello D, editors. Cecil Textbook of Medicine. 22nd ed. Philadelphia: Saunders Elsevier; 2004. p.2394-6.
 
4. Brown RH Jr, Mendell JR. Disorders of muscle membrane excitability. In: Braunwald E, et al, editors. Harrison's Principles of Internal Medicine. 15th ed. New York: McGraw-Hill; 2001. p.2538-40.
 
5. Ropper AH, Brown RH, editors. Disorders of the calcium channel. In: Adams and Victor's Principles of Neurology. 8th ed. New York: McGraw-Hill; 2005. p.1270-3.
 
6. Ropper AH, Brown RH, editors. Disorders of the sodium channel. In: Adams and Victor's Principles of Neurology. 8th ed. New York: McGraw-Hill; 2005. p.1268-70.
 
7. Ropper AH, Brown RH, editors. Thyrotoxic periodic paralysis. In: Adams and Victor's Principles of Neurology. 8th ed. New York: McGraw-Hill; 2005. p.1236.
 
8. Abrams GM, Zimmerman EA. Thyrotoxic periodic paralysis. In: Rowland LP, editor. Merritt's Neurology. 11th ed. Philadelphia: Lippincott Williams & Wilkins; 2005. p.1041.
 
P.351 掲載の参考文献
1. 杉本恒明, 古俣政男編. 内科学. 第6版. 東京: 朝倉書店; 1995. p.1451-70.
 
2. 庄司進一. 内分泌性筋疾患-病因, 病態, 病理. 杉田秀夫ほか編. 新筋肉病学. 東京: 南江堂; 1995. p.751.
 
3. 二川原健, 須田俊宏. Cushing 症候群と preclinical Cushing 症候群. 日本内科学会雑誌2006; 95: 642-9.
 
4. 宮森 勇. 原発性アルドステロン症. 厚生省特定疾患「副腎ホルモン産生異常症」調査研究班. 平成7年度研究報告書. 1996. p.227-8.
 
5. 須田道雄ほか. 筋原性酵素の上昇を伴った筋症状を主症状とした原発性アルドステロン症の2症例. 京都市立病院紀要 2001; 21: 84-90.
 
6. 伊藤裕ほか. 原発性アルドステロン症. 日本内科学会雑誌2006; 95: 634-41.
 
P.355 掲載の参考文献
1. 杉江秀夫, 杉江陽子. 代謝性筋疾患. 臨床検査2000; 46: 479-86.
 
2. 辻野精一. 筋糖原病(遺伝性糖代謝異常性ミオパチー). 神経研究の進歩2000; 2: 252-63.
 
3. 杉江秀夫, 杉江陽子. 糖代謝異常ミオパチー-診断と治療. 医学のあゆみ2003; 203(3): 189-92.
 
4. 福田冬季子. 代謝性ミオパチー. 小児内科2003; 35: 958-63.
 
5. DiMauro S, Bruno C. Glycogen storage diseases of muscle. Curr Opin Neurol 1998; 11(5): 477-84.
PubMed
6. Raben N, et al. Acid alpha-glucosidase deficiency(glycogenosis type II, Pompe disease). Curr Mol Med 2002; 2(2): 145-66.
PubMed
7. Hasselink RP, et al. Lysosomal dysfunction in muscle with special reference to glycogen storage disease type II. Biochim Biophys Acta 2003; 1637(2): 164-70.
 
8. Matern D, et al. Liver transplantation for glycogen storage disease types I, III, and IV. Eur J Pediatr 1999; 158 Suppl 2: S43-8.
 
9. Moses SW, Parvari R. The variable presentations of glycogen storage disease type IV: A review of clinical, enzymatic and molecular studies. Curr Mol Med 2002; 2(2): 177-88.
PubMed
10. Dimaur S, et al. Myophosphorylase deficiency(glycogenosis type V; McArdle disease). Curr Mol Med 2002; 2(2): 189-96.
PubMed
11. Wolf GI, et al. McArdle's disease presenting with asymmetric, late-onset arm weakness. Muscle Nerve 2000; 23(4): 641-5.
 
12. 杉江秀夫. 筋型糖原病. 小児内科2001; 33増: 168-9.
 
13. 福田冬季子ほか. 筋型糖原病の全国調査および浜松市発達医療総合センターにおける筋型糖原病診断症例の比較検討. 臨床神経学2003; 5: 243-8.
 
14. Winkel LP, et al. The natural course of non-classic Pompe's disease; A review of 225 published cases. J Neurol 2005; 252(8): 875-84.
 
15. Reuser AJ, et al. Enzyme therapy for Pompe disease: From science to industrial enterprise. Eur J Pediatr 2002; 161 Suppl 1: S106-11.
 
16. van den Hout HM, et al. The natural course of infantile Pompe's disease: 20 original cases compared with 133 cases from the literature. Pediatrics 2003; 112(2): 332-40.
PubMed
P.357 掲載の参考文献
1. 福田冬季子. 代謝性ミオパチー. 小児内科2003; 35増: p.958-63.
 
2. 米田 誠, 栗山 勝. 脂肪酸代謝異常によるミオパチー. Clinical Neuroscience 1999; 17(11): p.1241-4.
 
3. 佐藤史郎. カルニチン欠乏症候群. 別冊日本臨床 領域別症候群シリーズ36 骨格筋症候群 下巻. 大阪: 日本臨牀社; 2001. p.47-53.
 
4. 山口清次. ミトコンドリアβ酸化異常症(概論). 別冊日本臨床 領域別症候群シリーズ36 骨格筋症候群 下巻. 大阪: 日本臨牀社; 2001. p.60-4.
 
P.360 掲載の参考文献
1. 庄司進一. ステロイドミオパチーの成因と治療. 神経内科治療1988; 5: 233-9.
 
2. 市川陽一. ステロイドミオパチー. 医学のあゆみ1995; 173: 86-8.
 
3. Max SR, et al. Glucocorticoid receptor-mediated induction of glutamine synthetase in skeletal muscle cells in vitro. Endocrinology 1987; 120: 1179-83.
PubMed
4. Shoji S. Myofibrillar protein catabolism in rat steroid myopathy measured by 3-methylhistidine excretion in the urine. J Neurol Sci 1989; 93: 333-40.
PubMed
5. 松下達生ほか. ステロイドミオパチーに対する遺伝子組み換えヒト成長ホルモン(rhGH)の予防効果. 臨床神経 1996; 36: 752-6.
 
6. Kanda F, et al. Preventive effects of insulin-like growth factor-I on steroid-induced muscle atrophy. Muscle Nerve 1999; 22: 213-7.
PubMed
P.362 掲載の参考文献
1. Oh SJ. Alcoholic myopathy, a critical review. Ala J Med Sci 1972; 9: 79-95.
PubMed
2. Preedy VR, et al. The importance of alcohol-induced muscle disease. J Muscle Res Cell Motil 2003; 24: 55-63.
PubMed
3. 埜中征哉. アルコール性ミオパチー. 神経内科2005; 62: 461-6.
 
4. 真先敏弘, 鎌倉惠子. 慢性アルコール性ミオパチー. 別冊日本臨床 領域別症候群シリーズ36 骨格筋症候群 下巻. 大阪: 日本臨牀社; 2001. p.394-7.
 
5. Martin FC, et al. Alcoholic muscle disease. Br Med Bull 1982; 38: 53-6.
PubMed
6. Estruch R, et al. Natural history of alcoholic myopathy: A 5-year study. Alcohol Clin Exp Res 1998; 22: 2023-8.
PubMed
P.364 掲載の参考文献
1. Delay J, Deniker p.Drug-induced extrapyramidal syndromes. In: Vinken PJ, Bruyn GW, editors. Diseases of the Basal Ganglia: Handbook of Clinical Neurology. vol 6. New York: Elsevier; 1968. p.248.
 
2. 山脇成人. 悪性症候群の病態生理. 神経研究の進歩1998; 6: 933-7.
 
3. Caroff SN. The neuroleptic malignant syndrome. J Clin Psychiatry 1980; 41(3): 79-83.
PubMed
4. Pelonero AL, et al. Neuroleptic malignant syndrome: A Review. Psychiatr Serv 1998; 49: 1163-72.
PubMed
5. Caroff SN, Mann SC. Neuroleptic malignant syndrome. Med Clin North Am 1993; 77(1): 185-202.
PubMed
P.370 掲載の参考文献
1. Miller TM, Layzer RB. Muscle cramps. Muscle Nerve 2005; 32: 431-42.
PubMed
2. Parisi L, et al. Muscular cramps: Proposals for a new classification. Acta Neurol Scand 2003; 107: 176-86.
PubMed
3. Chiba S, et al. Autosomal dominant muscle cramp syndrome in a Japanese family. J Neurol Neurosurg Psychiatry 1999; 67: 116-9.
 
4. Ricker K, Moxley III RT. Autosomal dominant cramping disease. Arch Neurol 1990; 47: 810-2.
 
5. Satoyoshi E. A syndrome of muscle spasm, alopecia, and diarrhea. Neurology 1978; 28: 458-71.
PubMed
6. Endo K, et al. Improvement of Satoyoshi syndrome with tacrolimus and corticosteroids. Neurology 2003; 60: 2014-5.
PubMed
7. Isaacs H. A syndrome of continuous muscle fiber activity. J Neurol Neurosurg Psychiatry 1961; 24: 319-25.
 
8. Newson-Davis J, et al. Autoimmune disorders of neuronal potassium channels. Ann NY Acad Sci 2003; 124: 2417-26.
 
9. 有村公良. 筋緊張・けいれんの病態と治療: Issacs 症候群と stiff-man 症候群. 日内会誌1998; 87: 637-42.
 
10. Moersch FP, Woltman HW. Progressive fluctuating muscular rigidity and spasm("stiff-man" syndrome); report of a case and some observations in 13 other cases. Proc Staff Meet Mayo Clin 1956; 31: 421-7.
PubMed
11. Solimena M, DeCamilli p.Autoimmunity to glutamic acid decarboxylase(GAD)in stiff-man syndrome and insulin-dependent diabetes mellitus. Trends Neurosci 1991; 14: 452-7.
 
P.372 掲載の参考文献
1. Tein I, et al. Myoglobinuria. Myopathies. In:Vinken PJ, et al, editors. Handbook of Clinical Neurology, rev ser. Vol 60. New York: Elsevier Science; 1992. p.479-526.
 
2. 高木昭夫. ミオグロビン尿症. 豊倉康夫総編集, 萬年 徹, 金澤一郎編. 神経内科学書. 第2版. 東京: 朝倉書店; 2004. p.874-5.
 

9章 循環障害

P.378 掲載の参考文献
1. 三島好雄. 閉塞性動脈硬化症. 三島好雄, 稲垣義明編. 臨床脈管学. 東京: 文光堂; 1992. p.159-65.
 
2. 日本血管外科学会ホームページ参照. http://www.jsvs.org/ja/index.html
 
3. Norgren L, et al. Inter-Society Consensus for the Management of Peripheral Arterial Disease(TASC II). J Vasc Surg 2007; 45 Suppl: S5-67.
 
P.382 掲載の参考文献
1. Winiwarter F. Ueber eine eigenthumliche Form von Endarteriitis und Endophlebitis mit Gangran des Fusses. Arch Klin Chir 1878; 23: 202-26.
 
2. Buerger L. Thrombo-angiitis obliterans: A study of the vascular lesions leading to presenile spontaneous gangrene. Am J Med Sci 1908; 136: 567-80.
 
3. 三島好雄. Buerger 病. 木本誠二監修. 現代外科学大系〈年刊追補 1978-D〉. 東京: 中山書店; 1978. p.261-77.
 
4. 中島伸之. ビュルガー病(バージャー病)-Buerger's Disease-. 難治性血管炎の診療マニュアル. 厚生科学研究特定疾患対策研究事業 難治性血管炎に関する調査研究班. 2002. p.9-12.
 
5. Shigematsu H, et al. Current status and changing aspects of Buerger's disease in Japan. In: Nagasawa T, editor. Intractable Vasculitis Syndromes. Tokyo: Ministry of Health and Welfare of Japan; 1995. p.95-104.
 
6. Matsushita M, et al. Decrease in prevalence of Buerger's disease in Japan. Surgery 1998; 124: 498-502.
PubMed
7. Aerbajinai W, et al. HLA class II DNA typing in Buerger's disease. Int J Cardiol 1996; 54(Suppl): S197-202.
 
8. Hada M, et al. Cellular and humoral immune responses to vascular components in thromboangiitis obliterans. Angiology 1993; 44: 533-40.
PubMed
9. Iwai T, et al. Oral bacteria in the occluded arteries of patients with Buerger disease. J Vasc Surg 2005; 42: 107-15.
PubMed
10. 重松 宏ほか. 重症虚血肢をめぐる諸問題-日本の現状と診断基準. Therapeutic Research 1992; 13: 4099-109.
 
11. Herrington JL Jr, Grossman LA. Surgical lesions of the small and large intestine resulting from Buerger's disease. Ann Surg 1968; 168: 1079-87.
PubMed
12. Rosen N, et al. Intestinal Buerger's disease. Arch Pathol Lab Med 1985; 109: 962-3.
PubMed
13. Schellong SM, et al. Intestinal type of thromboangiitis obliterans(Buerger's disease). J Intern Med 1994; 235: 69-73.
PubMed
14. Harten P, et al. Multiple organ manifestations in thromboangiitis obliterans(Buerger's disease). A case report. Angiology 1996; 47: 419-25.
PubMed
15. Kessler C, et al. CAT scan and immunohistochemical findings in a case of cerebral thromboangiitis obliterans(Buerger's disease. Eur Neurol 1984; 23: 7-11.
 
16. Kurata A, et al. Thromboangiitis obliterans: Classic and new morphological features. Virchows Arch 2000; 436: 59-67.
PubMed
17. Shionoya S. Buerger's disease: Diagnosis and management. Cardiovasc Surg 1993; 1: 207-14.
PubMed
18. 三島好雄ほか. Buerger 病の動脈撮影像について. 昭和48年度厚生省ビュルガー病研究班報告書. 1974. p.24-7.
 
19. 重松 宏ほか. Buerger 病の大腿動脈分岐部病変について-動脈造影像による検討. 脈管学1984; 24: 1225-9.
 
20. 阪口周吉, 三島好雄. 血管造影所見報告I: Buerger 病について. 厚生省特定疾患系統的血管病変に関する調査研究班臨床分科会報告書. 1977. p.1-38.
 
21. 原 啓一. 下肢動脈撮影像に見られる蛇腹状陰影-その臨床例の分析と発生機序についての考察. 脈管学1970; 10: 461-74.
 
22. Matsushita M, et al. Urinary cotinine measurement in patients with Buerger's disease-Effects of active and passive smoking on the disease process. J Vasc Surg 1991; 14: 53-8.
PubMed
23. Hooten WM, et al. Inpatient treatment of severe nicotine dependence in a patient with thromboangiitis obliterans(Buerger's disease. Mayo Clin Proc 1998; 73: 529-32.
 
24. Fiessinger JN, Schafer M. Trial of iloprost versus aspirin treatment for critical limb ischaemia of thromboangiitis obliterans. The TAO study. Lancet 1990; 335: 555-7.
PubMed
25. The European TAO Study Group.Oral iloprost in the treatment of thromboangiitis obliterans(Buerger's disease): A doubleblind, randomised, placebo-controlled trial. Eur J Vasc Endovasc Surg 1998; 15: 300-7.
 
26. Isner JM, et al. Treatment of thromboangiitis obliterans(Buerger's disease)by intramuscular gene transfer of vascular endothelial growth factor: Preliminary clinical results. J Vasc Surg 1998; 28: 964-75.
PubMed
27. Morishita R, et al. Safety evaluation of clinical gene therapy using hepatocyte growth factor to treat peripheral arterial disease. Hypertension 2004; 44: 203-9.
PubMed
28. 大橋重信. Buerger 病と動脈硬化との関係について-臨床的, 動脈撮影的, 病理学的考察. 日外会誌1975; 76: 491-506.
 
P.388 掲載の参考文献
1. Kakkar VV, et al. Natural history of postoperative deep-vein thrombosis. Lancet 1969; 2: 230-2.
PubMed
2. Lagerstedt CI, et al. Need for long-term anticoagulant treatment in symptomatic calf vein thrombosis. Lancet 1985; 2: 515-8.
PubMed
3. Passman M, et al. Pulmonary embolism is associated with the combination of isolated calf vein thrombosis and respiratory symptoms. J Vasc Surg 1997; 25: 39.
PubMed
4. Lutter KS, et al. Superficial thrombophlebitis diagnosed by duplex scanning. Surgery 1991; 110: 42.
PubMed
5. Hayes TM, et al. Antithrombotic therapy for venous thromboembolic disease. Chest 2001; 119: 176-93S.
 
6. Linkins L, et al. Clinical impact of bleeding in patients taking oral anticoagulant therapy for venous thromboembolism: A metaanalysis. Ann Intern Med 2003; 139: 893-900.
PubMed
7. Comercta AJ, et al. Catheter-directed thrombolysis for iliofemoral deep venous thrombosis improves health-related quality of life. J Vasc Surg 2000; 32: 130-7.
 
8. Meissner MH, et al. Deep venous insufficiency: The relationship between lysis and subsequent reflux. J Vasc Surg 1993; 18: 596.
PubMed
9. Meissner MH, et al. Propagation, rethrombosis, and new thrombus formation after acute deep venous thrombosis. J Vasc Surg 1995; 22: 558.
PubMed
P.393 掲載の参考文献
1. Arosa S, Sidawy AN. Lower extremity aneurysm. In: Ernst CB, Stanley JC, editors. Current Therapy in Vascular Surgery. 4th ed. St Louis: Mosby; 2001. p.331-45.
 
2. Van Bockel JH, Hamming JF. Lower extremity aneurysms. In: Rutherford RB, editor. Vascular Surgery. 6th ed. Philadelphia: Elsevier Saunders; 2005. p.1534-51.
 
3. Clagett Gp.Upper extremity aneurysms. In: Rutherford RB, editor. Vascular Surgery. 6th ed. Philadelphia; Elsevier Saunders; 2005. p.1551-6.
 
4. Sasaki S, et al. Surgical experience of the thoracic aortic aneurysm due to Takayasu's arteritis. Int J Cardiol 2000; 75 Suppl 1: S129-34.
 
5. Graham AN, et al. Risk of rupture of postangiographic femoral false aneurysm. Br J Surg 1992; 79: 1022-5.
PubMed
6. Siauw R, et al. Endovascular repair of popliteal artery aneurysms: Techniques, current evidence and recent experience. ANZ J Surg 2006; 76: 505-11.
PubMed
7. Tielliu IF, et al. Endovascular treatment of popliteal artery aneurysms: Results of a prospective cohort study. J Vasc Surg 2005; 41: 561-7.
PubMed
8. Vermilion BD, et al. A review of one hundred forty-seven popliteal aneurysms with long-term follow-up.Surgery 1981; 90: 1009-14.
PubMed
9. Whitehouse WM Jr, et al. Limb-threatening potential of arteriosclerotic popliteal artery aneurysms. Surgery 1983; 93: 694-9.
PubMed
10. Mahmood A, et al. Surgery of popliteal artery aneurysms: A 12-year experience. J Vasc Surg 2003; 37: 586-93.
PubMed
11. Pulli R, et al. Surgical management of popliteal artery aneurysms: Which factors affect outcomes? J Vasc Surg 2006; 43: 481-7.
PubMed
12. Graham LM, et al. Clinical significance of arteriosclerotic femoral artery aneurysms. Arch Surg 1980; 115: 502-7.
PubMed

書評

最近チェックした商品履歴

Loading...